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INTRODUCTION 
Part of "the essence of being eukaryotic" is the possession of 
mitochondria, the cytoplasmic organelles responsible for the generation 
of most of the cellular ATP. The biological origin of these organelles 
has puzzled researchers for many years. Microscopic observations sug­
gested that they multiplied by binary fission (Palade, 1953) much like 
bacteria. Their ellipsoidal shape and physical structure, e.g., 
possession of a double lipid bilayer, also suggested a relationship with 
the prokaryotes but the meaning of these similarities remained unclear. 
Recently investigators have begun to speculate that an early event on 
the ancestral cell's road to becoming eukaryotic was the capture and 
domestication of a bacterium capable of aerobic respiration (Margulis, 
1971; Sagan, 1967). The organism was referred to as an aerobic, 
amitotic, amoeboid cell. This cell then underwent a profound modifica­
tion of the symbiotic relationship between host and promitochondrial 
genomes, eventually resulting in the present day eukaryotic cell. One 
early impetus for this theory was the discovery of DNA in mitochondria. 
Nass and Nass (1963) using electron microscopy were the first to 
demonstrate that mitochondria contained discrete pieces of DNA. Shortly 
after this. Luck and Reich (1964) showed that nuclear DNA and mitochon­
drial DNA from N. crassa had distinctly different base compositions. 
This was the first biochemical evidence that mitochondria contained DNA 
molecules distinct from those of the nucleus. Subsequently, mitochon­
drial DNA from numerous sources was characterized and the results sug­
gest that the two genetic systems are undergoing a gradual but 
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essentially Independent evolution of base composition (Rabinowitz and 
Swift, 1970). 
Mitochondrial DNAs from the various kingdoms of eukaryotes are 
quite different from each other. The mitochondrial DNA of all animals 
thus far investigated (including humans, frogs, fruit flies and sea 
urchins) occurs as a 5 pm, supercoiled, covalently closed, circular 
duplex with a molecular weight of 8 to 10 million daltons (Borst, 1972). 
More complex forms such as catenated or circular dimers are also known 
to occur (Hudson e^  al., 1968). Yeast mitochondrial DNA occurs as a 
25 ym circle of about 50 million daltons. It has not been isolated 
intact but the circular form has been visualized by electron microscopy 
(Hollenberg et^  al^ ., 1970). Using even the gentlest of techniques, it 
is possible to Isolate only randomly sheared molecules which are one-
half to one-third the length of the intact genome (Locker e^  al., 1974). 
DNA from Neurospora is similar to that of yeast but somewhat smaller 
(20 ym) (Agsteribbe et_ al., 1972). The only linear mitochondrial genome--
so far discovered occur in the ciliated protozoans—Paramecium and 
tetrahymena (Cummlngs et al, 1976; Goldbach et al., 1976). In higher 
plants, the molecule is again circular but with a contour length of 30 ym 
making it the largest mitochondrial DNA molecule known (Koldner and 
Tewari, 1972). Mitochondrial DNA from most sources, including human, 
has a very low guanine plus cytosine content, ca. 20% to 30% (Borst and 
Kroon, 1969). In yeast, this low G plus C content reflects the occur­
rence of fairly long tracts of dA:dT and dTArdAT as well as a preference 
for GC exclusive codons in the known coding regions of the genome 
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(Bernard!, 1976). There do not, however, seem to be any corresponding 
regions in the human mitochondrial genome, and codon selection is 
limited to a preference for G in the third position (Barrel al., 1979). 
The complete DNA sequence of the human mitochondrial genome has been 
determined (Anderson et^  , 1981) ; bovine mitochondrial DNA has also 
been sequenced (mentioned in Anderson at , 1981). 
Despite early reports by Swanson (1971) and Dawid and Chase (1972), 
it now seems clear that most, if not all, of the RNA found in mitochondria 
is transcribed from mitochondrial DNA (Borst, 1972; Fukahara, 1970; Mahler 
and Dawidowicz, 1973). In HeLa cells, both strands of the mitochondrial 
DNA are completely transcribed into higji molecular weight RNA which are 
then processed into tRNA, rRNA, and mRNA (Murphy et al., 1975). The 
strand having the highest buoyant density in alkaline cesium chloride 
(the H-strand) codes for the two ribosomal RNAs, the majority of the 
known tRNAs and most of the poly(A) containing RNAs (Aloni and Attardi, 
1971a; Angerer et al., 1976; Lynch and Attardi, 1976). The majority of 
the L-strand transcript is rapidly degraded and, during long term 
labeling, products of the H-strand predominate. L-strand products, 
which represent less than 2% of the total RNA hybridizable to mitochon­
drial DNA (Aloni and Attardi, 1971b; Attardi et al., 1970), comprise seven 
tRNAs and one small poly(A) containing RNA (Amalric et al., 1978). 
A total of 19 mitochondrial tRNAs have been shown to hybridize to 
human mitochondrial DNA (Angerer et al., 1976; Lynch and Attardi, 1976). 
From DNA sequence data, an additional 3 tRNA genes have been identified, 
bringing the final count to 22 (Anderson e^  , 1981). Transfer RNA 
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does not seem to be imported into mammalian mitochondria (Aujame and 
Freedman, 1979); therefore, 22 or 23 may be an upper limit to the number 
of tRNA species existent in the mitochondria. This amazing finding then 
raises the question of how these few tRNAs are able to read all the 
codons of the genetic code, a task which requires a minimum of 32 tRNAs 
according to the wobble hypothesis of Crick (1966). Two possibilities 
which present themselves are restricted codon usage by the mitochondrial 
mRNAs and unusual codon-reading abilities of the tRNAs. It seems the 
latter may be the correct explanation. In three papers published 
simultaneously. Barrel et al. (1980), Bonitz et al. (1980), and Heckman 
et al. (1980), suggested that in humans, Neurospora and yeast, some 
mitochondrial tRNAs are able to read all the codons of a four-codon 
family. For example, a single mitochondrial tRNA is able to decode UCN 
(where N is any nucleotide) as serine. The mitochondrial tRNAs 
apparently accomplish this by having an unmodified U in the first 
position of the anticodon. U is the only base which can form stable 
base pairs with either A, G, C, or U (Lagerkvist, 1978). When U occurs 
in the first position of a prokaryotic or eukaryotic cytoplasmic tRNA, 
it is always modified (Sprinzl et , 1980) presumably to limit 
recognition to less than all four bases. The single known exception is 
yeast tRNA^  ^which contains an unmodified U and can somehow recognize 
all six leucine codons (Randerath et , 1979). In codon families 
where two different amino acids are specified, e.g., glutamate CGAG, GAA) 
and aspartate (GAU, GAG), the purines in the third position are read by 
an anticodon with a modified U in the first position, the nature of the 
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modification is unknown; the pyrimidines are read by a G in the first 
position. With this system, AUA would then code for methionine instead 
of isoleucine and UGA would code for tryptophan. These coding changes 
have been shown to occur in the mitochondrial tRNAs (Bonitz et , 1980; 
Heckman et al., 1980; Martin et al., 1980). In the mammalian system, 
it has been suggested that AGA and AGG as well as UAA and UAG code for 
termination. This would reduce the number of tRNAs required for complete 
decoding of the mitochondrial code to 22 (Barrel et , 1980). 
It is Interesting to note that the formation of the proposed U:C 
and U:U base pairs involves a significant conformational change in the 
codon (Grosjean et al., 1978) which may, in part, be accommodated by the 
unusual structures of some of the mitochondrial tRNAs, e.g., RNA and DNA 
sequence data has shown that a mitochondrial seryl-tRNA is completely 
devoid of the dihydrouridine loop found in all other tRNAs (Arcari and 
Brownlee, 1980; de Bruijn et al., 1980). This conformational change, 
not required in other systems, may also be facilitated by the structure 
of the mitochondrial ribosome (see discussion below). It is not known 
whether heterologous ribosomes could permit such changes. Studies using 
purified mitochondrial tRNAs to translate messages on homologous and 
heterologous ribosomes might reveal more restricted coding properties 
for the tRNAs under the latter conditions (Heckman e^  , 1980). 
Some mitochondrial mRNAs have been found to contain polyadenylic 
acid (poly(A)) at their 3'-0H end (Ojala and Attardi, 1974; Perlman et 
al., 1973). Unlike the longer (up to 170 nucleotides) terminal poly(A) 
sequences found at the 3' ends of cytoplasmic messengers (Darnell et al.. 
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1971), mitochondrial mRNAs have only 50 to 80 residues in their poly(A) 
tails. In this respect, the mitochondrial mRNAs may be intermediate 
between that of the prokaryote and the eukaryote. A 7MeG linked to the 
5' terminal nucleotide through a 5' to 5' triphosphate is known to "cap" 
eukaryotic mRNA (Both e^  al., 1975). Shafritz ^  (1976) have 
reported that this eukaryotic cap participated directly in the interac­
tion of the mRNA with eukaryotic initiation factor IF-M^  during initia­
tion of protein synthesis. Mitochondrial mRNAs seem to lack a 5' capping 
structure but in the light of the more "bacterial" nature (see below) of 
mitochondrial protein synthesis, this might have been expected 
(Grohmann et al., 1978). 
Recently Attardi £t al. (1976) have identified 18 different poly(A) 
containing RNAs from HeLa mitochondria. Of these, only the eight 
smallest can be fit into the presumed mRNA coding regions on the genetic 
map of the HeLa mitochondrial genome. The rest are presumably incom­
pletely processed precursor molecules. There are, coincidently, only 
nine known products of mitochondrial translation. These are the three 
largest subunits of cytochrome c oxidase, one of the subunits of the 
cytochrome b complex and four separate subunits which constitute a 
specific membrane site for the integration of mitochondrial oligomycin-
sensitive ATPase complex (Schatz and I-Iason, 1974; Tzagoloff et al., 
1973). Rabinowitz and associates have shown that translation of yeast 
mitochondrial poly(A)-containing RNA in an ^  coli in vitro system gives 
rise to products which include peptides precipitable by antibodies to 
authentic subunits of cytochrome c oxidase (Padmanaban et al,, 1975; 
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Rabinowitz et , 1976). At least one protein associated with the 
mitochondrial ribosomes of yeast (Var 1) and Neurospora (S-5) is also 
translated on mitochondrial ribosomes (Lambowitz et al», 1976; La Polla 
and Lambowitz, 1977; Terpstra et al., 1979). As the products of animal 
mitochondrial translation bear a qualitative and quantitative resem­
blance to those of yeast when analyzed on SDS gels, it seemed likely 
that few, if any, translation products remained to be identified 
(O'Brien and Matthews, 1976). However, eight other unidentified 
reading frames (URFs), presumably additional protein coding genes, have 
been located in the human and bovine mitochondrial DNA sequence 
(Anderson ^  , 1981) . 
All the known products of mitochondrial translation are integrated 
into multimeric functional units to which both the nuclear and mitochon­
drial genomes make a contribution (Schatz and Mason, 1974). The best 
studied example of this interaction is the biosynthesis of cytochrome c 
oxidase in the yeast mitochondrion. Cytochrome c oxidase is a trans­
membrane protein (Eytan e^  al., 1975) composed of seven individual 
polypeptides. Subunits I, II, and III are synthesized in the mitochon­
dria while subunits IV, V, VI, and VII are synthesized in the cytoplasm 
(Mason and Schatz, 1973; Rubin and Tzagoloff, 1973). The biosynthesis 
of these cytoplasmic and mitochondrial components is, as expected, 
interdependent. Poyton and Kavanaugh (1976) showed that synthesis of 
subunits I, II, and III but not other products of isolated yeast 
mitochondria was dependent upon a specific cytoplasmic stimulating 
factor. This factor was immunologically related to subunits IV and 71. 
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Tryptic peptide analysis of this 55,000 dalton precursor revealed that 
it had the same peptide composition as a mixture of all the subunits 
made by the cytoplasm. Interestingly, processing of the precursor takes 
place after it enters the membrane and entry is the signal for stimula­
tion of synthesis of the mitochondrially made subunits. The precursor 
is able to enter the inner membrane in the absence of bound cytoplasmic 
ribosomes. It has since been shown that the cytoplasmically synthesized 
subunits of the ATPase complex and the cytochrome b complex are likewise 
made as larger precursors (Schatz, 1979) which may subsequently be 
processed after entry into the inner membrane. 
Biosynthesis of mitochondrial ribosomes may be controlled in a 
manner similar to the one outlined above. In Neurospora, the mitochon­
drially synthesized small subunit protein S-5 has been shown to play a 
significant role in the assembly of the small subunit by facilitating 
processing of the 19S RNA and stabilizing the binding of several cyto­
plasmically synthesized proteins (JLambowitz et al., 1976; La Polla and 
Lambowitz, 1977). In the absence of functional S-S, e.g., in the poky 
mutation, or when its synthesis is inhibited by chloramphenicol, there 
are significant aberrations in processing the small subunit precursor 
(Lambowitz et al., 1979). A similar effect has been noted for the small 
subunit protein Var 1 in yeast (.Terpstra et , 1979). 
McLean £t (1958) were the first to demonstrate that isolated 
but intact rat liver mitochondria were able to incorporate radioactively 
labeled amino acids into high molecular weight polypeptides. The 
findings of Rendi (1959) and Mager (1960) that incorporation of amino 
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acids by this system could be inhibited by chloramphenicol, a drug 
known to act on bacterial ribosomes, suggested that a rlbosorae might be 
involved in the polymerization. Further evidence for the existence of 
a ribosome unique to the mitochondria was presented by Kroon (1963) and 
Kalf (1963) who showed that puromycin, a known analogue of the 3* end 
of aminoacyl-tRNA, would also inhibit mitochondrial protein synthesis. 
Andre and Marinozzi (1965), using electron microscopy, finally provided 
visual evidence with the observation of small rlbonuclease sensitive 
particles inside the mitochondrion. 
Unlike cytoplasmic ribosomes, mitochondrial ribosomes from the dif­
ferent kingdoms are structurally quite distinct. Among the fungi, 
mitocondrial ribosomes have been isolated from S. cerevisiae (Schmitt, 
1971), Neurospora crassa (Kuntzel and Noll, 1967), and Candida utilis 
(Vignais et ^ ., 1972). These ribosomes are all quite similar and 
possess sedimentation coefficients between 72S and 78S. They contain 
large and small subunit RNAs with sedimentation coefficients in the 
ranges 21S to 24S and 16S to 17S, respectively. No small RNAs such as 
the 5S and 5.8S RNAs of the cytoplasmic ribosome have been reported. 
The mitochondrial ribosomes of the protozoa seem to differ con­
siderably even between orders. The mitochondrial ribosomes of Euglena 
gracilis have a sedimentation coefficient of 71S with subunits of 50S 
and 32S (Avadhani and Buetow, 1972a) while the mitochondrial ribosomes 
of Crithedia luclllae sediment at 60S with subunits of 45S and 32S 
(Laub and Thirion, 1972). The difference is even greater when different 
phyla are compared. The mitochondrial ribosomes of the ciliated 
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protozoan Tetrahymena pyrlformls sediment at 80S and dissociate into two 
subunits with identical sedimentation coefficients of 55S (Chi and 
Suyama, 1970). 
Plant mitochondrial ribosomes sediment at 77S to 78S with subunits 
of 60S and 44S (Leaver and Harmey, 1972). The mitochondrial ribosomes 
of higher plants, in contrast to those of fungi, protozoa or animal 
cells, have been shown to contain a 5S RNA which is present in equimolar 
amounts with the large components of the mitochondrial rRNA (Leaver and 
Harmey, 1976). They do not contain a 5.88 RNA. In this respect, they 
resemble bacterial ribosomes. 
Mitochondrial ribosomes from all animal sources so far investigated 
bear a remarkable structural and functional similarity (O'Brien and 
Matthews, 1976). They have a narrow range of sedimentation values (54S 
to 61S with subunits approximately 40S and 30S) which are considerably 
lower than those of previously studied bacterial or eukaryotic ribosomes 
(Kleinow et al., 1971; O'Brien, 1971; O'Brien and Kalf, 1967; Perlman 
and Penman, 1970; and Swanson and Dawid, 1970). An early conclusion 
(Borst and Grivell, 1971) that animal mitochondrial ribosomes were mini-
ribosomes, e.g., of low molecular weight and/or small size, was sup­
ported by the small size of their rRNAs. The large subunit RNA weighs 
5-5.8 X 10^  and the small subunit RNA, 2,8-3.5 x 10^  daltons (Dawid and 
Chase, 1972; Kleinow et al., 1974; Robberson et al., 1971; Sacchl et al., 
1973). The miniribosome concept was put in question, however, by the 
findings that mitochondrial ribosomes had a slightly higher total 
molecular weight, 2.8 x 10^  daltons, CHamilton and O'Brien, 1974) than 
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did the bacterial ribosomes, 2.6 x 10^  daltons, (Hill et al., 1969) and 
had a larger volume as well (DeVries and Van der Koogh-Schuuring, 1973). 
It now seems clear that the lower sedimentation coefficient of the 
animal mitochondrial ribosome is largely due to its lower boyant den­
sity, a reflection of a higher protein to RNA ratio (Hamilton and 
O'Brien, 1974; Leister and Dawid, 1974; Perlman and Penman, 1970). In 
fact, while E. coli ribosomes are known to have 54 different proteins 
(Stoff1er and Wittmann, 1977), animal mitochondrial ribosomes have been 
shown to contain as many as 94 separate proteins (O'Brien and Matthews, 
1976). Present evidence suggests that all of these proteins are 
required for functional activity (O'Brien et al., 1976). 
There were enormous difficulties experienced in purifying mitochon­
drial ribosomes, as evidenced by the appreciable lag between their dis­
covery (McLean et al., 1958) and the isolation of a reasonably pure 
ribosome preparation (Kuntzel and Noll, 1967; O'Brien and Kalf, 1967). 
These difficulties were caused, in part, by the lack of any clear-cut 
criteria to distinguish between authentic mitochondrial ribosomes, 
cytoplasmic ribosomes, and bacterial ribosomes originating from chance 
contamination of the isolation medium. The problem of bacterial con­
tamination was remedied by assuring that all buffers and apparatus used 
in the isolation were sterile before and during use. The problem of 
contaminating cytoplasmic ribosomes was partially circumvented by using 
selective vivo labeling in the presence of any one of a variety of 
specific inhibitors. For example, the mitochondrial ribosome can be 
labeled in its RNA component by growing cells in the presence of 
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3 [ H]-uridine and low levels of actinoraycin D (0.04-0.1 yg/mL). This 
technique was used by Attardi and Ojala (1971) and Brega and Vesco (1971) 
to demonstrate that HeLa cell mitochondria contain a ribonucleoprotein 
which sediments at 55S to 60S. This particle contained two stable RNAs 
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of 16s and 12S and was able to incorporate [ H] leucine into nascent 
polypeptide ^  vivo in the presence of cyclohexitnide but not chloram­
phenicol. These mitochondrial ribosome preparations were heavily con­
taminated with cytoplasmic ribosomes but because of differential 
labeling a distinction could be made. 
Animal mitochondrial ribosomes were first isolated by O'Brien and 
Kalf (1967) from the livers of young rats. The preparations were free 
of cytoplasmic and bacterial contamination but were not active in in 
vitro polypeptide synthesis. In 1973, Ibrahim et al., using a 
modification of the procedure of O'Brien and Kalf (1967), and Greco et 
al. (1973), were able to isolate rat liver mitochondrial ribosomes 
which were active in poly(U)-directed polyphenylalanine synthesis and 
which were more active than the preparation of O'Brien and Kalf in tiie 
peptidyl transferase assay. Both systems used ^  coli supernatant 
factors and were inhibited by low levels of chloramphenicol. Greco et 
al. (1973) purified their mitochondria using three washes in 1 mM EDTA 
rather than the extensive washing through discontinuous gradients used 
by Ibrahim et al. (1973), but both preparations still required sucrose 
gradient purification to remove cytoplasmic ribosomes. In that same 
year, DeVries and Van der Koogh-Schuuring (1973) used digitonin washed 
mitochondria to prepare rat liver mitochondrial ribosomes free of 
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cytoplasmic contamination as judged by sucrose gradient centrifugation 
and gel electrophoresis. The preparations were not active in in vitro 
polypeptide synthesis. Then, in 1974, Avadhani and Rutman combined EDTA 
washing and digitonin treatment to prepare mitochondrial ribosomes from 
Ehrlich acites cell mitochondria. These preparations were active in 
poly(U)-directed polypeptide synthesis using either mitochondrial or 
bacterial supernatant factors and did not require further purification 
on sucrose gradients. Mitochondrial ribosomes active in protein 
synthesis have also been isolated from yeast (Ibrahim et , 1973), 
Xenopus (Swanson, 1973) and Euglena (Avadhani and Buetow, 1972b). 
Although animal mitochondrial and bacterial ribosomes seem to be 
completely unrelated at the level of gross structure, as pointed out 
above, they do have certain functional similarities. Protein synthesis 
is initiated on mitochondrial ribosomes using formylated methionyl-tRNA 
(Schatz and Mason, 1974) just as in bacterial systems and the initiation 
and elongation factors are believed to be interchangeable with those from 
bacteria (Avadhani and Buetow, 1972b; Grandi et al., 1971; Griyell et al., 
1971); however, recent studies by Denslow and O'Brien (1979) and Ulbrich 
et al. (1980) on the species specificity of elongation factor G suggest 
that the homology may not be as extensive as once thought. It is clear, 
however, that mitochondrial ribosomes are able to use bacterial tRNAs for 
translation of synthetic messages (Schatz and Mason, 1974). 
In 1960, Mager pointed out that amino acid incorporation into 
isolated animal mitochondria was inhibited by the drug chloramphenicol, 
an antibiotic whose inhibition of bpctgrial ribosomes in general and the 
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E. coll peptldyl transferase center In particular has been well docu­
mented (Pestka, 1977; Vasquez, 1979). Subsequent studies have shown 
that mitochondrial ribosomes are sensitive to most of the Inhibitors of 
bacterial ribosomes but that the degree of sensitivity may be quite 
different (Denslow and O'Brien, 1974). 
Chloramphenicol has been shown to inhibit the peptldyl transferase 
center of bovine mitochondrial ribosomes (Denslow and O'Brien, 1978). 
This suggests but does not prove that the mode of action of chloram­
phenicol may be the same in mitochondrial as in bacterial systems. In 
bacterial systems chloramphenicol acts by binding to the 50S subunit in 
the vicinity of the acceptor site (A site) (Lessard and Pestka, 1972). 
Irradiation of this complex leads to covalent attachment of the chloram­
phenicol and irreversible Inactlvation of the peptldyl transferase 
center of the ribosome (Sonnenberg et al., 1974). Many antibiotics 
which bind to the 50S subunit interfere, to one extent or another, with 
the binding of chloramphenicol (Pestka, 1977). Inhibition of peptldyl 
transferase activity is probably due to blockage of the rlbosomal A site 
either sterically or allosterically by the drug. This is suggested by 
the observations that: 1) chloramphenicol is a competitive inhibitor 
of puromycln in the formation of peptidyl-puromycin (Pestka, 1972). As 
puromycin Is an analogue of the 3' end of an amlnoacyl-tRNA, this sug­
gests that chloramphenicol may act by directly blocking the functional 
attachment of the 3' terminus of tRNA; 2) chloramphenicol blocks the 
binding of aminoacyl-oligonucleotides but not N-acetyl-aminoacyl-
oligonucleotides to the ribosome (Celma et al., 1970; Lessard and 
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Pestka, 1972). This demonstrates directly that chloramphenicol inhibits 
the binding of the 3' end of aminoacyl-tRNA to the A site but not the P 
site of the ribosome. Prevention of the functional attachment of an 
aminoacyl-tRNA easily accounts for the inhibition of peptide bond 
formation (Pestka, 1977; Vasquez, 1979). 
Interestingly, chloramphenicol does not inhibit aminoacyl-oligonu-
cleotide binding to ribosomes in all systems equally. Higher concentra­
tions of the drug are required for 50% inhibition of the binding of 
phenylalanyl-oligonucleotides than are required for the same effect on 
lysine-, leucine-, or serine-containing oligonucleotide fragments 
(Hishizawa and Pestka, 1971; Pestka e^ .^, 1970). Inhibition of poly-
nucleotide-directed polypeptide synthesis by chloramphenicol has been 
found to be template dependent as well. Poly(U)-directed peptide 
synthesis is significantly more resistant to inhibition by the drug than 
is poly(.C,U)- or poly (A)-directed synthesis (Kucan and Lipmann, 1964; 
Vasquez, 1966). Because poly(U) codes for polyphenylalanine, both 
effects may be the result of a greater affinity of phenylalanyl-tRNA 
for the ribosome (Pestka, 1977; Vasquez, 1979). 
There have been numerous reports of acquired resistance to chloram­
phenicol by prokaryotic cells. Resistance usually occurs via one of 
two major biochemical mechanisms. The first involves an acquired 
impermeability of the cell membrane to the drug. This can occur as 
the results of an episomal transfer, or of multi-step mutations (Okamoto 
and Mizuro, 1962, 1964). Alternatively, transfer of an episome carrying 
the gene for a chloramphenicol acetyl-transferase, which acetylates 
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chloramphenicol to the inactive diacetyl derivative, can occur (Okamoto 
and Suzuki, 1965; Shaw et al., 1970). A third mechanism for resistance, 
mutation of a ribosomal constituent, seems to be a comparatively rare 
event (Pestka, 1977). The difficulty of obtaining ribosomal mutations 
to chloramphenicol resistance may be due to the occurrence of multiple 
gene copies of ribosomal RNA in most organisms (Smith, 1977)• If muta­
tion to chloramphenicol resistance involves a change in the rRNA 
sequence, then only genetic systems with single copy rRNA genes, e.g., 
cell organelles, would be easily mutable. By selection of a cell 
resistant to erythronycin. Cerna and Rychlik (1968) obtained a strain 
of coli with ribosomes which were resistant to inhibition by chloram­
phenicol as well. Later Osawa et al. (1973) isolated a chloramphenicol 
resistant mutant of ^  subtilis and were able to show that the resistance 
was due to alterations of ribosomal proteins but no other examples of 
chloramphenicol resistant ribosomes have been reported in bacteria. In 
eukaryotic cells, resistance to chloramphenicol has been reported for 
yeast (Bunn et al., 1970), mouse (Bunn et al., 1974) and human 
(Mitchell ^  al•, 1975; Spolsky and Eisenstadt, 1972) cell lines. 
In 1972, Spolsky and Eisenstadt successfully isolated a fast 
growing, chloramphenicol resistant mutant of HeLa S^  cells which they 
designated 296-1. They had induced the mutation with ethidium bromide, 
a mutagen known to preferentially affect mitochondrial DNA (Leibowitz, 
1971); but this did not exclude the possibility that the mutation was of 
nuclear origin. In order to clarify this point, Wallace et al. (1975) 
fused cytochalasin produced cytoplasts (cells which have been 
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enucleated) prepared from the chloramphenicol resistant cell line with 
chloramphenicol sensitive cells containing a nuclear mutation which 
inactivated the enzyme thymidine kinase. The resulting cybrids 
(cytoplasmic hybrids) were then plated in medium containing chloram­
phenicol and the thymidine analog 5-bromodeoxyuridine, conditions which 
inhibited the growth of both parental lines. Finding the cybrids were 
able to grow in this medium provided substantial evidence that the 
mutation to chloramphenicol resistance resided on a mitochondrial gene. 
By measuring peptide synthesis in mitochondria permeabilized by treat­
ment with a low concentration of Triton X-100, Spolslqr and Eisenstadt 
(1972) had shown that resistance was not due to an alteration in the 
mitochondrial membrane rendering it impermeable to the drug. In a 
later paper, Kislev et al. (1973) reported that chloramphenicol induced 
large alterations in the mitochondrial ultra-structure of HeLa but 
not 296-1, again supporting the belief that the loss of cytotoxicity was 
due to an alteration in some aspect of mitochondrial protein synthesis. 
The above mentioned results have three likely possibilities to 
account for drug resistance; induction or mutation of a preexisting, 
mitochondrially encoded enzyme capable of acting on the drug and 
directly rendering it inactive (the mitochondrial equivalent of the 
plasmid encoded bacterial transacetylase); induction or mutation of a 
mitochondrially encoded protein- or RNA-modifying enzyme capable of 
modifying some constituent of the protein synthetic machinery (ja 
ribosomal protein, RNA or translation factor); an alteration in a 
structural gene encoding either a ribosomal protein, RNA or translation 
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factor. In order to decide among these possibilities, a regime for the 
isolation and purification of human mitochondrial ribosomes and a 
protein synthesis assay system that is sensitive to inhibition by 
chloramphenicol was established. Results with this system show that 
mitochondrial ribosomes from the chloramphenicol resistant line of HeLa 
cells are resistant to the drug ^  vitro, thus clearly demonstrating 
that antibiotic resistance is due to a functional modification of the 
ribosome itself. Recent sequence analysis of yeast (Dujon, 1980) and 
mouse and human (Blanc et al., 1981; Kearsey and Craig, 1981) mitochon­
drial DNA have identified single nucleotide changes in the 3' region of 
the large (21S) rRNA gene which correlate with the antibiotic resistance. 
Similar findings were made with HeLa 296-1 (D. C. Wallace, Stanford 
University, unpublished observations). 
In a larger context, the work described in this thesis is part of 
an ongoing effort to characterize the complex interactions required of 
the products of the nuclear and mitochondrial genetic systems during 
mitochondrial biogenesis. Central to these considerations is the 
description of an ^  vitro polypeptide synthesizing system which is 
totally of mitochondrial origin and in which mitochondrial mBNA is 
translated into polypeptide that is identical to the in vivo product. 
This work is a first step toward accomplishing that end with a system 
of human origin. 
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EXPERIMENTAL PROCEDURES 
Origin of Cell Lines 
Both HeLa cell lines used in these experiments were obtained from 
Dr. J. M. Eisenstadt of the Department of Human Genetics, Yale University 
School of Medicine. The chloramphenicol resistant line was isolated as a 
mutant of HeLa by treating the cells for one generation with ethidium 
bromide (0.5 uM), washing the cells free of mutagen and growing them for 
several generations in medium containing 50 pg/mL chloramphenicol. At 
the end of this time several clones were selected and one, a fast growing 
line designated 296-1, was employed in these studies (Spolsky and 
Eisenstadt, 1972). 
Conditions for Cell Growth 
Cell lines were maintained as stock cultures by growth in monolayers 
2 
on 25 cm tissue culture flasks in minimum essential medium (MEM) (Eagle, 
1959) supplemented with 10% (v/v) serum; in the majority of experiments 
an equal mixture of horse and calf serum was used. The plates were 
incubated at 37°C in a humidity controlled atmosphere of 5% COg to main­
tain the pH of the medium. The cells were fed every other day by replacing 
the spent medium with 5 mL of fresh medium. When the cells reached con-
fluency, they were removed from the flask by trypsinization in phosphate 
buffered saline solution (PBS) containing 0.05% trypsin. The cells were 
then counted in a hemocytometer and replated after dilution with fresh 
medium to a density of 1 x lo"^  cells/mL. The medium used to maintain the 
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drug resistant cell line contained 50 pg/mL chloramphenicol to suppress 
revertants and minimize the possibility of cross contamination during 
passage. The sensitive cell line was assayed periodically for continued 
sensitivity to the drug by preparing growth curves in the presence of 
50 yg/mL chloramphenicol (Spolsky and Eisenstadt, 1972). 
Cell stocks were prepared for frozen storage by trypsinizing a plate 
as described earlier and collecting the cells by centrifugation at 300 x 
Gave for 10 minutes. After washing with PBS the cells were resuspended 
at a concentration of 1 x 10^  cells/mL in minimum essential medium supple­
mented with 10% dimethylsulfoxide and the suspension pipetted onto several 
small screw cap freezer vials. These were chilled rapidly in an ice 
water bath, wrapped in tissue paper, packed in a thick-walled polystyrene 
container and stored at -70°C. After 24 hours a sample of the frozen 
cells was checked for viability by thawing and plating out an appropriate 
dilution in fresh MEM containing serum. Viabilities of 90% or better 
were not unusual. Cells frozen by this procedure remained viable for up 
to 6 months (the longest period checked). 
2 For preparative scale growths, cells were plated onto two 125 cm 
flasks and these were grown to confluency as described above. The plates 
were then trypsinized and the entire culture diluted to a cell density 
not less than 5 x 10^  cells/mL in a 250 mL spinner flask. In spinner 
culture, the cells were grown in RPMI 1640 supplemented with 6% serum 
(an equal mixture of horse and calf serum) and 0.03% glutamine. An 
aliquot of the suspension culture was counted daily in a hemocytometer 
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and fresh medium was added to maintain a cell density of not less than 
4-5 X 10^  cells/raL. Doubling time of the cells in spinner culture was 
usually 24-28 hours. Cells were harvested when the volume of culture was 
8-16 liters and a small volume of cells (250-500 mL) was saved to initiate 
the next growth, thus avoiding restarting the spinner culture from stock. 
Harvesting the Cells 
When the cells had reached the desired volume and density, they were 
transferred, aseptically, into autoclaved 500 mL centrifuge bottles with 
0-ring seals and centrifuged at 440 x G for 10 minutes in a Beckman 
ave 
J-21C centrifuge. The pelleted cells were then washed by resuspension in 
NKMT buffer (0.14M NaCl; O.OOIM Tris-HCl, pH 7.4; 0.00015M MgClgZ O.OIM 
KCl) and centrifugation at 440 x This process usually yielded 
2-3 g of cells/L. 
Isolation of Mitochondria 
Washed cells were resuspended in TKM buffer (O.OIM Tris-HCl, pH 7.4; 
O.OIM KCl; 0.00015M MgCl2)» 6 mL/g of cells, and allowed to swell for 10 
minutes at 4°C. At the end of this time, the cells were examined in a 
microscope to observe the effects of the hypotonic swelling. With well 
swollen cells a distinct nucleus surrounded by a ring of cytoplasm is 
visible; swollen cells are approximately twice the normal diameter. The 
cells were then broken by homogenization (10-15 strokes) in a Thomas 
tissue homogenizer with a motor driven Teflon pestle rotating at 1,500 
rpm. One tenth volume of TS buffer (2.5M sucrose; O.OIM Tris-HCl, pH 7.4) 
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was quickly added and nuclei and unbroken cells were pelleted by centri-
fugation at 1,200 x for 3 minutes. The supernatant was saved and the 
pellet resuspended in one half the initial volume of TKM and again 
homogenized. After addition of one tenth volume of TS buffer the homo-
genate was centrifuged at 1,200 x for 3 minutes and the supernatants 
from the two centrifugations were combined. The remaining pellet, which 
contained mostly nuclei, was discarded. The combined supernatants were 
then centrifuged at 11,900 x G for 10 minutes to sediment the mito-
ave 
chondria. The postmitochondrial supernatant was either discarded or used 
to prepare cytoplasmic ribosomes. Crude mitochondria were resuspended 
in 100 mL of ST buffer (0.25M sucrose; O.OIM Tris-HCl, pH 7.4; 100 ug/mL 
bovine serum albumin) or, in later experiments, in STE buffer (ST buffer 
plus 0.002M EDTA) and again centrifuged at 11,900 x for 10 minutes. 
This washing procedure was repeated 1 to 4 times. After being washed, 
the mitochondria were resuspended in 10 to 20 mL of ST buffer and the 
absorbance of a standard dilution was read at 550 nm. The amount of 
mitochondrial protein in the preparation was estimated from a standard 
curve which related the absorbance at 550 nm to total mitochondrial pro­
tein as determined by the method of Lowry e^  (1951). 
Digitonin Treatment of Purified Mitochondria 
The washed mitochondrial preparation was diluted to 20 mg mitochon­
drial protein/mL with ST buffer. An equal volume of ST buffer containing 
3.0 mg/mL digitonin was added dropwise with stirring at 0°C. The digi­
tonin solution, always freshly prepared, was made by dissolving a weighed 
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amount of digitonin in ST buffer heated in a boiling water bath; the 
solution was rapidly cooled on ice just before use. After the final 
addition of digitonin, the solution was stirred at 0°C for 2 minutes, then 
rapidly diluted with 3 volumes of ice cold ST buffer and centrifuged at 
19,000 X for 5 minutes. The pellet was resuspended in one-half the 
above volume of ST buffer and centrifuged at 19,000 x for 10 minutes. 
This wash step was repeated once more and the digitonin treated mitochon­
dria recovered by centrifugation at 19,000 x G^ ^^  for 20 minutes 
(Loewenstein e^  al., 1970). 
Incubation of Mitochondria wtih Puromycin and ATP 
Digitonin treated mitochondria were resuspended in ATP buffer (0.15M 
KCl; O.OIM MgCl^ ; O.OIM KH^ PO^ , pH 6.7; 0.002M ATP; 0.005M 2-ketoglutarate; 
2 mg/mL BSA) at 20 mg/mL and were incubated 10 minutes at 37°C. Puromycin 
(O.IM) was then added to a final concentration of O.lmM and incubation was 
continued for an additional three minutes. At the end of this time the 
mitochondria were pelleted by centrifugation at 20,000 x G^ ^^  for 10 
minutes. 
Preparation of Ribosomes 
Mitochondrial Ribosomes 
The digitionin treated mitochondrial pellet was weighed and resus­
pended by homogenization in KMEDT buffer (O.IM Tris-CHl, pH 7.4; O.OIM 
MgClg; O.IM KCl; 0.002M DTT; O.OOOIM EDTA) to a final concentration of 
35 mg/mL (wet weight). Mitochondria were then lysed by the addition of 
24 
one tenth volume of a detergent mixture containing 5% Brij-58 and 5% 
Nonidet P-40 (w/v). After homogenization with 5-6 strokes in a tissue 
horaogenizer, the mixture was allowed to sit at 0°C for 5 minutes before 
insoluble material was removed by centrifugation at 20,000 x for 20 
minutes. The straw-colored supernatant was layered over a 2 mL pad of 
IM sucrose in KMEDT buffer and centrifuged at 105,000 x G for 16 hours 
ave 
in a Beckman Type 40 rotor. After centrifugation, the supernatant and 
half of the sucrose pad were removed with a pasteur pipette and the walls 
of the centrifuge bottles were washed with distilled water. The remaining 
portion of the sucrose pad was then removed and the bottles were drained 
by inverting them in an ice bucket. The small yellow pellets were 
resuspended by homogenization in 0.3 mL of KMEDT buffer. The ribosome 
solution was clarified by centrifugation at 20,000 x G^ ^^  for 20 minutes 
and the supernatant was then divided into 0.05 mL aliquots, quick frozen 
and stored in liquid nitrogen until used. Ribosomes were thawed just 
prior to use and any unused portion was discarded as they could not be 
refrozen with retention of full activity. 
Cytoplasmic Ribosomes 
To be used as sedimentation markers and for the preparation of 
cytoplasmic ribosomal RNA, cytoplasmic ribosomes were prepared from the 
postmitochondrial supernatant. This fraction was layered over 3 mL of 
IM sucrose in KMEDT buffer and centrifuged at 105,000 x G for 16 hours 
ave 
in a Beckman Type 40 rotor. The supernatant and sucrose pad were dis­
carded and the pellets were resuspended in 3-4 mL of KMEDT buffer. 
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Insoluble material was removed by centrifugation at 20,000 x for 
20 minutes and the supernatant was divided into 0.2 mL aliquots, quick 
frozen and stored in liquid nitrogen until used. 
Bacterial Ribosomes 
Escherichia coli strain B (3/4 log phase), grown on enriched medium, 
was purchased from the Grain Processing Corp., Muscatine, Iowa as a frozen 
paste. Cells were broken by grinding with alumina (Alcoa A-305) in the 
cold for 30 minutes. The resulting paste was suspended in TMA2 buffer 
(O.OIM Tris-HCl, pH 7.4; 0.0IM MgClg: 0.06M NH^ Cl) containing 2 pg/mL 
deoxyribonuclease. Ribosomes were prepared by differential centrifugation 
as described by Tissieres e^  (1959). They were washed twice with TMA2 
buffer, then once with TMA2 buffer containing 0.5M NH^ Cl. The resulting 
ribosomal pellet was resuspended in TMA2 buffer and dialyzed against the 
same buffer. Ribosomes were stored frozen at -70°C. The concentration of 
ribosomes was calculated from the absorbance at 260 nm using a value of 
Rate Zonal Centrifugation in Sucrose Gradients 
Linear gradients of 10% to 30% sucrose were prepared in KMEDT buffer 
and samples, in volumes no greater than 200 pL, were layered directly on 
top. The gradients were then centrifuged at 40,000 rpm in a Beckman SW 
40 rotor for 3 hours or at 27,000 rpm in a Beckman SW 27.1 rotor for 
8 hours. Under these conditons a peak sedimenting at 55S migrated to 
the middle of the centrifuge tube. After centrifugation, fractions of 
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0.4-0.5 mL were collected from the top of the gradient using a Buchler 
Densi-Flo gradient fractionator. Fractions were analyzed for radioac-
tivity either directly, when incorporation of [ H]-uridine into ribosomes 
was determined, by addition of 5 mL of toluene-Triton-PPO scintillation 
cocktail (2 L toluene; 1 L Triton X-100; 19 g PPO) after dilution with 
1 mL of HgO or following TCA precipitation. In the latter procedure 
0.5 mL of 10% TCA was added and the samples were heated at 90°C for 20 
minutes. After cooling, the precipitate was collected on Millipore 
filters, dried and counted in toluene-PPO scintillation cocktail (3.6 L 
toluene; 19 g PPO; 0.32 g POPOP). The hot TCA treatment completely 
solubilized radioactivity present in ribosomal RNA, so that it did not 
interfere with the detection of labeled polypeptide. 
Radioactive Labeling of Ribosomal RNA vivo 
3 
Mitochondrial ribosomal RNA was labeled with [ H]-uridine, in the 
absence of nuclear ribosomal RNA synthesis, by preincubating a liter of 
cells (5-7 X 10^  cells/mL) with 0.05 yg/mL actinomycin D for 30 minutes, 
followed by addition of [^ H]-uridine (20-30 Ci/mMole; 0.5 mCi/mL (Dubin 
and Monteenecourt, 1970; Zylber e^  , 1969). The actinomycin D was pre­
pared as a stock solution, 100 yg/raL, in 95% ethanol. Cells were har­
vested ca. 16 hours later, and the labeled cells were combined with a 
larger volume of unlabeled cells before further processing. When labeling 
of both cytoplasmic and mitochondrial ribosomal RNA was desired, cells 
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were grown with [ H]-uridine in the absence of actinomycin D. 
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Extraction of Mitochondrial and Cytoplasmic Ribosomal RNA 
Ribosomal RNA from both cytoplasmic and mitochondrial ribosomes was 
prepared by the method of Lambowitz and Luck (1976). Ribosomes contain­
ing 50,000 to 70,000 cpm of [^ H]-uridine were diluted to 2 mL with 
extraction buffer (O.IM NaCl; 0.025M Tris-HCl, pH 7.4; 1% SDS; 0.002M 
EDTA; 10 jJg/mL polyvinyl sulfate) . coli tRNA (100 yg) was added as 
carrier and protein was degraded by incubation at 37°C for 20 minutes 
with 100 yg/mL pronase. The enzyme had been predigested by incubation 
at 37°C for 1 hour before use. The mixture was then shaken with an equal 
volume of phenol/chloroform/isoamyl alcohol (25:25:1) for 20 minutes at 
room temperature and the phases separated by centrifugation. The organic 
phase was discarded and the extraction process repeated. RNA in the com­
bined aqueous phases was then precipitated by the addition of 2 volumes 
of ice cold 95% ethanol. The precipitate was stored at -20°C for at least 
2 hours and was then collected by centrifugation at 20,000 x G for 
ave 
20 minutes; the pelleted RNA was dissolved in 2 mL of distilled HgO. 
One tenth volume of 20% potassium acetate, pH 5 was added and the RNA 
was reprecipitated with 2 volumes of ethanol. After at least 2 hours at 
-20°C,the precipitate was collected by centrifugation and the final RNA 
pellet was resuspended in 50 yL of distilled, deionized HgO, quick frozen, 
and stored in liquid nitrogen until used. 
Electrophoresis of Mitochondrial and Cytoplasmic Ribosomal RNA 
Electrophoresis of mitochondrial and cytoplasmic rRNA was performed 
according to the method of Gegenheimer ^  al.. (1977) in 0.5 x 10 cm 
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cylindrical tubes. The 3% polyacrylamide gels (acrylamide.'bis-acrylamide, 
15:1) were prepared in a buffer containing: 0.04M Tris-HCl, pH 7.8; 3% 
glycerol; O.OOIM EDTA; 0.2% SDS and were polymerized by the addition of 
0.12% TEMED and 0.12% (NH^ )2S20g. [\]-ribosomal RNA samples (5-7 x 10* 
cpm) were diluted with an equal volume of 2X sample buffer (40% sucrose 
in O.OIM Tris-CHl, pH 7.4; O.IM KCl; O.OIM MgClg; 0.1% bromphenol blue) 
and layered directly on top of the gel beneath the electrode buffer. 
Electrophoresis was usually carried out at 3 mA/gel for 4 hours. The 
electrode buffer contained 0.04M Tris-acetate, pH 7.4; 3% glycerol; and 
O.OOIM EDTA. After electrophoresis, gels were removed from the tubes by 
means of a water filled bulb and prepared for counting by the procedure of 
Loening (1967). Each gel was sliced into 1 mm discs which were placed 
into individual glass scintillation vials. One half mL of 10% (v/v) 
piperidine was added and the vials were heated to dryness at 60°C for 
several hours. Then 0.5 mL of H^ O was added and the gels were allowed to 
swell to many times their original size. Five mL of toluene-Triton-PPO 
scintillation cocktail were added; the samples were mixed and allowed to 
stand in the dark at room temperature overnight. The following day they 
were mixed again and counted. 
Preparation of Protein Synthesis Supernatant Factors (S-100) 
Mitochondiral S-100 was prepared according to the procedure of 
Denslow and O'Brien, 1979. All operations were carried out at 0 to 4°C. 
Liver (rabbit or rat), excised from a freshly sacrificed animal, was 
chilled and washed by immersion in 300 mL of buffer A (0.34M sucrose; 
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0.005M Tris-HCl, pH 7.4). It was then blotted dry, weighed, and minced 
with scissors. The minced tissue was resuspended (5 mL/g) in buffer A 
and homogenized with 3 strokes of a tissue homogenizer fitted with a 
motor driven Teflon pestle rotating at 1,500 rpm. Unbroken cells and 
nuclei were removed by centrifugation at 1,100 x for 15 minutes. The 
mitochondria were then pelleted by centrifugation at 10,000 x for 
10 minutes and washed repeatedly by resuspension in buffer A and centrifu­
gation. Washed mitochondria were resuspended in 25 mL of buffer B 
(0.02M Tris-HCl, pH 7.6; O.OIM KCl; 0.015M MgClg: 0.006M 2-mercaptoethanol) 
and sonicated with a Branson Cell Disruptor Model 200 (4 minutes at 50% 
duty cycle, setting number 7). The sonicate was centrifuged 20,000 x G^ ^^  
for 20 minutes. The KCl concentration of the supernatant was adjusted to 
0.5M, and it was layered on 10 mL of IM sucrose in KMEDT buffer and 
centrifuged 9 hours at 105,000 x in a Beckman Type 70Ti rotor. The 
upper half of the supernatant was dialyzed against buffer B and then 
concentrated to 3 mL with Aquacide and stored frozen at -20°C. 
An S-100 from ^  coli was prepared by grinding cells with alumina 
as described for ribosome preparation. The cell paste was resuspended 
in TMA2 buffer containing 0.006M 2-mercaptoethanol and the alumina and 
cell debris were removed by low speed centrifugation (10,000 x G^ ^^  for 
10 minutes). The resulting supernatant was then centrifuged at 
105,000 X G^ ^^  for 4 hours. The upper 2/3 of this high speed supernatant 
was divided into aliquots and stored frozen at -70°C until used. 
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Polypeptide Synthesis Assays 
Poly(U)-directed polypeptide synthesis 
Assay mixtures contained, in a final volume of 0.1 mL, O.OIM Tris-HCl; 
pH 7.4; 0.05M KCl; 0.045M (NH^ igSO^ ; 0.012M MgCl^ ; 0.005M 2-mercapto-
ethanol; 0.005M dithiothreitol; O.OOIM ATP; 0.0004M GTP; 0.004M PEP; 
4.5 units pyruvate kinase; 30 yg E. coli S-100 (or variable amounts of 
mitochondrial S-100); 45 yg 50 yM of each amino acid except 
3 phenylalanine; 1.5 yM [ H]-phenylalanine (50-60 Ci/iriMole) and ribosomes 
as indicated. Reactions were started by immersing the tubes in a water 
bath at 37°C, and terminated by the addition of 3 mL 5% trichloroacetic 
acid (TCA). The incubation period was usually one hour. After precipi­
tation with TCA, reaction mixes were heated to 90°C for 20 minutes and 
then cooled on ice for at least 20 minutes. The precipitate was collected 
on Millipore filters, washed 3 times with ice cold 5% TCA, dried and 
counted in 5 mL toluene-PPO scintillation cocktail. 
Poly(C,U)-directed polypeptide synthesis 
The assay mixture was formulated exactly as above, except that the 
nonradioactive amino acid mixture lacked phenylalanine, leucine, and pro-
3 3 line and contained 2 yM serine. 1 yM each [ H]-phenylalanine, [ H]-
3 proline, and [ H]-leucine were added and 50 yg poly(C,U) was used in place 
of poly(U). 
Kinetic studies 
For studies of reaction rates, samples of at least 50 yL were removed 
from a scaled up incubation mixture. After taking the zero time sample. 
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the assay was begun by immersing the remaining incubation mixture in a 
water bath at 37°C. At the appropriate times, samples were removed and 
precipitated with TCA. After all samples were collected the tubes were 
heated and further processed for counting as described earlier. 
RNase Assay 
The procedure was that described by Gribnau ^  aj^ . (1970), and mea­
sured the hyperchromicity at 260 nm resulting from the hydrolysis of an 
RNA sample. Each assay was made up to a final volume of 0.6 mL by adding 
to 0.2 mL of distilled, deionized HgO: 0.1 mL IM Tris-HCl, pH 7.4: 0.2 mL 
cytoplasmic ribosomal RNA (15 mg/mL); and 0.1 mL of the solution to be 
assayed. The mixture was incubated for 30 minutes at 37°C, an equal 
volume of IN HCL in 76% ethanol was added to each assay tube before it 
was chilled on ice for 1 hour. After centrifugation at 2,000 x for 
30 minutes, 0.5 mL of the supernatant was taken, diluted with 2.5 mL H^ O 
and the absorbance at 260 nm was read in a 0.2 cm cell blanked against 
H^ O. The assay was standardized by using pancreatic RNase dissolved in 
HgO containing 0.1% bovine serum albumin at a concentration of 0.05 pg/mL. 
Materials 
All enzymes and E. coli tRNA were from Sigma Chemical Co., St. Louis, 
Missouri. Media for cell culture were obtained from Grand Island Bio­
logical Co., Grand Island, New York. The polynucleotides, poly(U) and 
poly(C,U) were obtained from P & L Biochemicals. Sephadex G-75 was 
purchased from Parmacia, Inc. DEAE-cellulose was Whatman microgranular 
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3 grade DE-32. [ H]-labeled amino acids were from New England Nuclear. 
Ribonuclease free sucrose was from Schwarz/Mann. Chloramphenicol and 
cycloheximide were products of Sigma Chemical Co.; other antibiotics 
were a gift of Dr. Jerome Eisenstadt. All other reagents used were of 
analytical grade or higher. 
Phenol was distilled before use to remove Impurities and the dis­
tillate was stored at 4°C in the dark. Dialysis tubing was treated by 
boiling in 0.0054M NagEDTA; 0.014M NaHCO^  and 0.007M 2-mercaptoethanol 
for 30 minutes to remove heavy metal and enzyme contaminants. The tubing 
was then thoroughly washed with deionized water and stored at A°C. 
Acrylamide and N,N-methylene bisacrylamide were obtained from Eastman 
Kodak and were recrystallized before use according to the procedure of 
Loaning (1967). 
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RESULTS 
Isolation and Activity of Mitochondrial Ribosomes 
Mitochondrial ribosomes, labeled in their RNA, were prepared from 
3 digitonin treated mitochondria of cells grown in the presence of I H]-
uridine and actinomycin D as described in the Experimental Procedures 
Section. Under these conditions, only mitochondrial ribosomes become 
labeled (Dubin and Monteenecourt, 1970). When these ribosomes were 
analyzed by sucrose gradient centrifugation, three major peaks were seen 
(Figure lA). Using cytoplasmic ribosomes (748), centrifuged in a parallel 
tube as a standard, these peaks were assigned sedimentation coefficients 
as indicated in the figure, under the assumption that sedimentation 
through these gradients was isokinetic. Sedimentation coefficients of 
55S for the monomer, and 40S and 30S for the large and small subunits, 
respectively, are in good agreement with published values for mammalian 
mitochondrial ribosomes (Attardi and Ojala, 1971; Avadhani et al., 1975; 
Brega and Vesco, 1971; Neupert, 1977; O'Brien and Matthews, 1976). 
In order to estimate the level of cytoplasmic contamination, ribo­
somes were prepared from the mitochondria of cells grown in the presence 
3 
of [ H]-uridine but in the absence of actinomycin D. When these ribo­
somes were examined by sucrose gradient centrifugation, an additional 
peak sedimenting at 74S was seen (Figure IB). The sedimentation behavior 
of this peak was indistinguishable from that of authentic cytoplasmic 
ribosomes under these conditions. Suppression of label incorporation 
into this peak by low levels of actinomycin D, was a strong indication 
Figure 1. Centrifugatlon profile of mitochondrial ribosomes 
Mitochondrial ribosomes were prepared from HeLa S3 cells 
labeled in vivo with [^ H]-uridine in the presence (Figure 
lA) or absence (Figure IB) of 50 ng/mL actinomycin D, 
The ribosomes were separated by centrifugatlon through a 
10-30% sucrose gradient for 8 hours at 27,000 rpm. 
Fractions were prepared for liquid scintillation counting 
as outlined in Experimental Procedures Section. 
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that this component represented contaminating cytoplasmic ribosomes 
(Dubin and Monteenecourt, 1970). 
Mitochondrial ribosomes, prepared as described, were active in 
protein synthesis with either poly(U) or poly(C,U) as messenger. As 
shown in Table 1, synthesis of polypeptide was dependent upon supple­
mentation with both synthetic message and mitochondrial ribosomes. 
Cycloheximide (2 mg/mL) was included in the reaction to suppress poly­
peptide synthesis by cytoplasmic ribosomes. To demonstrate that the 
product formed was synthesized on mitochondrial ribosomes, we took 
advantage of the observation by O'Brien and Kalf (1967) that nascent 
polypeptide remains associated with ribosomes during sucrose gradient 
centrifugation. Isolated mitochondrial ribosomes were incubated in the 
polyphenylalanine synthesizing system for 60 minutes at 37°C. The 
mixture was then layered directly on top of a 10-30% sucrose gradient 
and centrifuged for 8 hours at 27,000 rpm in a Beckman Type SW 27.1 
rotor. Fractions were collected starting from the top of the gradient 
3 
and were analyzed for [ H]-polyphenylalanine by trichloroacetic acid 
precipitation and liquid scintillation counting as outlined in the 
Experimental Procedures Section. In a parallel reaction, cytoplasmic 
ribosomes were incubated in an assay mixture from which cycloheximide 
had been excluded. The results, shown in Figure 2, reveal that the 
product synthesized on mitochondrial ribosomes sedimented at 55S and 
could easily be distinguished from product synthesized by the cytoplasmic 
ribosomes which sedimented at 74S. 
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Table 1. Polypeptide synthesis by isolated mitochondrial ribosomes^  
3 (A) Poly(U)-directed incorporation of [ H]-phenylalanine 
Mixture CPM 
Complete 48,600 
-Ribosomes 14,100 
-Poly(U) 16,300 
3 (B) Poly(C,U)-directed incorporation of [ H]-leucine 
Mixture CPM 
Complete 35,800 
-Ribosomes 13,400 
-Poly(C,U) 19,200 
P^olypeptide synthesis assays were conducted as described in the 
Experimental Procedures Section, and included 2 mg/mL cycloheximide to 
inhibit polypeptide synthesis by cytoplasmic ribosomes. 
Figure 2. Sucrose gradient centrifugation of nascent polypeptides 
associated with mitochondrial (55S) and cytoplasmic (74S) 
ribosomes 
q 
[ H]-polyphenylalanine was synthesized in a poly(U)-
directed reaction mixture which contained either 
mitochondrial (o-o) or cytoplasmic (•-•) ribosomes. 
After incubation, the nascent polypeptide was 
visualized by sucrose gradient centrifugation as 
described in Figure 1. 
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These mitochondrial rlbosome preparations were contaminated with 
cytoplasmic rlbosomes as shown In Figure 3. In the absence of cyclo-
hexlmlde, a peak of nascent polypeptide was observed on sucrose gradients, 
sedlmentlng at the position expected for cytoplasmic rlbosomes. This 
activity was suppressed by cycloheximidé (Figure 3) with little or no 
inhibition of mitochondrial rlbosome activity. High concentrations of 
cycloheximide were found necessary to obtain effective inhibition of 
cytoplasmic rlbosome activity when assayed under the conditions outlined 
in the Experimental Procedures Section (Table 2), A more detailed 
examination of the protein synthetic activity of the mitochondrial 
rlbosome will be presented later. 
Purification of Mitochondrial Rlbosomes 
from Contaminating Cytoplasmic Rlbosomes 
The degree of contamination with cytoplasmic rlbosomes varied 
from one mitochondrial preparation to another. To minimize this 
contamination, rlbosomes were prepared from mitochondria which had been 
treated with dlgitonin by a modification of the procedure of Loewenstein 
 ^ (1970) (See Experimental Procedures Section). This produced 
mltoplasts by removing the outer mitochondrial membrane together with 
adhering cytoplasmic rlbosomes. In an attempt to optimize the dlgitonin 
treatment for recovery and activity of HeLa cell mitochondrial rlbosomes, 
as well as removal of contaminating cytoplasmic rlbosomes, the effect 
of several different concentrations of the detergent was examined. 
Figure 3. Sucrose gradient centrifugation of nascent polypeptides 
synthesized in the presence or absence of cycloheximide 
Ribosoraes from digitonin treated mitochondria were 
incubated in a poly(U) directed polypeptide synthesis 
mixture in the presence (•-•) or absence (o-o) of 
1 mg/mL cycloheximide. After incubation, the nascent 
[3H]-polyphenylalanine was visualized by sucrose gradient 
centrifugation (10 to 30% sucrose gradient centrifuged 
8 hrs at 27,000 rpm in a Beckman SW27.1 rotor). Gradient 
fractions were prepared for liquid scintillation counting 
as outlined in Experimental Procedures Section. 
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Table 2. Effect of cycloheximide on poly(U)-directed polypeptide 
synthesis by 74S cytoplasmic ribosomes^  
(Cycloheximide) 
3 [ H]-polyphenylalanine 
CPM (-zero time) % 
0 166,000 100 
0.4 mg/mL 135,000 81 
1.0 mg/mL 107,000 64 
2.0 mg/mL 72,000 43 
A^ssay conditions were as noted in Experimental Procedures Section. 
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3 In these experiments, cells were grown in [ H]-uridine without 
actinomycin D in order to label both mitochondrial and cytoplasmic ribo-
somes. Mitochondria were isolated as described under Experimental 
Procedures and treated with increasing amounts of digitonin. Ribo-
somes isolated from these mitochondria were then examined by centri-
fugation on 10-30% sucrose gradients. Figure 4 shows the results of 
treatment with 0, 0.15, 0.20 and 0.25 mg digitonin per mg of mitochon­
drial protein. Mitochondrial ribosome preparations from untreated 
mitochondria were heavily contaminated with cytoplasmic ribosomes. At 
a ratio of 0.15 mg digitonin per mg of mitochondrial protein, the 
extent of 74S ribosome contamination was greatly decreased with no 
concomitant loss of 55S ribosomes. Higher digitonin concentrations, 
however, resulted in a significant loss of 55S material. A concen­
tration of digitonin of 15-20 mg per rag ribosomal protein gave optimal 
results. 
The effectiveness of digitonin in removing cytoplasmic ribosomes 
can also be observed by examining the sedimentation behavior of nascent 
polypeptide synthesized by the mitochondrial ribosome preparations. 
Sucrose gradient profiles of poly(U)-directed polypeptide synthesis 
assays (without cyclohexiraide) using mitochondrial ribosomes prepared 
from mitochondria treated with varying concentrations of digitonin are 
shown in Figure 5. The heavy contamination with functionally active 
cytoplasmic ribosomes in the ribosome preparations made without 
3 detergent is apparent from the large peak of [ H]-labeled polypeptide 
Figure 4. Effect of treatment with varying concentrations of 
digitonin on the recovery of mitochondrial and 
cytoplasmic ribosomes 
Mitochondria were prepared from HeLa cells labeled 
with [%]-uridine in the absence of actinomycin D. 
They were then treated with digitonin at varying 
ratios of detergent to mitochondrial protein. The 
ribosomes were subsequently isolated and examined 
by sucrose gradient centrifugation as described in 
Figure 1. Detergent to protein ratios were; 
Figure 4a, no digitonin (o-o), 0.15 mg digitonin/mg 
mitochondrial protein (•-•); Figure 4b, 0.20 mg/mg 
(•-•) and 0.25 mg/mg (o-o). 
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Figure 5. Sucrose gradient centrifugation of nascent polypeptides 
synthesized on mitochondrial ribosomes prepared with 
and without digitonin 
Ribosomes prepared from mitochondria untreated with 
digitonin (Figure 5a) or from mitochondria treated 
with digitonin (Figure 5b), at concentrations of 0.15 
(o-o) or 0.25 (•-•) mg/mg of mitochondrial protein, 
were incubated in a poly(U)-directed polypeptide 
synthesis mixture containing no cyclohexdmide. After 
60 minutes of incubation, the newly synthesized [3H]-
polyphenylalanine was visualized by centrifugation 
through a 10 to 30% sucrose gradient (3 hrs at 40,000 rpm 
in a Beckman SW 40Ti rotor). Gradient fractions were 
prepared for liquid scintillation counting as out­
lined in the Experimental Procedures Section. 
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sedlmenting at 74S (Figure 5A). Ribosomes Isolated from mitochondria 
washed with 0.15 and 0.25 mg dlgltonin per mg mitochondrial protein had 
greatly reduced levels of active cytoplasmic ribosomes (Figure 5B). 
At the higher digitonin concentration, there was a significant decrease 
in the amount of polypeptide associated with mitochondrial ribosomes 
and sedlmenting at 55S (Figure SB). 
It was concluded from these results that a digitonin to mitochondrial 
protein ratio of 0.15 represented the optimal conditions for isolation of 
mitochondrial ribosomes, and all subsequent mitochondrial preparations 
were treated with digitonin at this level. 
Despite digitonin treatment, mitochondrial preparations were not 
entirely free from contamination by cytoplasmic ribosomes. Additional 
methods of purification were therefore sought. Lewis et (1976) 
washed ascites cell mitochondria with 2 mM EDTA (in addition to washing 
with digitonin) to remove cytoplasmic ribosomes from their preparations. 
In order to assess the effect of EDTA treatment of mitochondria on HeLa 
cell mitochondrial ribosomes, mitochondria were prepared from cells 
3 grown in [ H]-uridine without actinomycin D (see Experimental Procedures 
Section). Before treatment with digitonin the mitochondrial preparation 
was divided into two portions. One was washed twice with ST buffer and 
the other with the same buffer containing 2 mM EDTA. When the vivo 
labeled ribosomes prepared from these mitochondria were examined on 
sucrose gradients, it was clear that EDTA washing had greatly reduced 
the level of contaminating cytoplasmic ribosomes (Figure 6). The 
Figure 6. Effect of EDTA treatment on the recovery of mitochondrial 
and cytoplasmic ribosomes 
Mitochondria were prepared from HëLa cells labeled with 
[%]-uridine in the absence of Actinomycin D. The mito­
chondria were then washed twice with ST buffer alone (o-o) 
or with ST buffer containing 2 mM EDTA (•-•) and then 
treated with digitonin. Ribosomes were isolated and 
examined by centrifugation at 40,000 rpm for 3 hrs through 
10-30% sucrose gradients (K^ IEDT buffer) in a Beckman 
SW-40Ti rotor. Gradient fractions were prepared for 
liquid scintillation counting as described in the Experi­
ment Procedures Section. 
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effectiveness of washing with EDTA in removing cytoplasmic ribosomes 
was confirmed by examining the products of poly(U)-directed polypeptide 
synthesis by these ribosomes preparations on sucrose gradients. As 
shown in Figure 7, washing mitochondria with 2 mM EDTA resulted in a 
major reduction of the amount of polyphenylalanine associated with 
cytoplasmic ribosomes (74S), while no loss of polypeptide sedimenting 
with mitochondrial ribosomes (55S) was observed. 
These results, while encouraging, did not conclusively prove that 
cytoplasmic ribosomes were actually absent from the mitochondrial ribo-
some preparations. It was possible that the EDTA caused cytoplasmic 
ribosomes to dissociate into subunits of 60S and 4OS which would be 
indistinguishable from the mitochondrial ribosome monomer (555) and 
large subunit (40S), on sucrose gradients. To rule out this possibility 
it was necessary to identify the ribosomal RNA species present in our 
preparations. 
ENA was extracted from ribosomes isolated from mitochondria that 
had been prepared with and without EDTA and was examined by electro­
phoresis in 3% polyacrylamide gels (see Experimental Procedures Section). 
As a standard, authentic cytoplasmic rRNA was electrophoresed in a 
parallel gel. The IBS rRNA of the cytoplasmic small subunit and the 16S 
rRNA of the mitochondrial large subunit were poorly resolved under our 
conditions (results not shown) ; however, the presence of 28S rRNA from 
the large cytoplasmic ribosomal subunit could easily be detected. 
Figure 8 shows the results of such an experiment. Ribosomal RNA from 
Figure 7. Sucrose gradient centrifugation of nascent polypeptides 
synthesized by ribosomes from mitochondria treated with 
digitonin and EDTA 
Ribosomes from mitochondria prepared with (o-o) and 
without (•-•) EDTA treatment were incubated in a 
poly(U)-directed polypeptide synthesizing system. 
Nascent [^ Hl-polyphenylalanine was visualized by 
sucrose gradient centrifugation as described in 
Figure 6. Gradient fractions were prepared for 
liquid scintillation counting as described in the 
Experimental Procedures Section. 
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Figure 8. Polyacrylamide gel electrophoresis of RNA prepared 
from mitochondrial ribosomes 
Mitochondria (digitonin treated) were prepared from 
HeLa cells labeled with [^ H]-uridine in the absence 
of actinomycin D. The mitochondria were washed 5 
times with ST buffer (A) or with ST buffer containing 
2 mM EDTA (B). Ribosomes were prepared and RNA 
extracted as described under Experimental Procedures. 
The RNA was separated by electrophoresis in 3% poly­
acrylamide at 3mA per gel for 4 hours. The gels were 
sliced and the fractions prepared for liquid 
scintillation counting. Authentic 28S and IBS rRNAs 
were electrophoresed in parallel gels as markers. 
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the preparation made without EDTA shows a large 28S cytoplasmic rRNA 
component (Figure 8A) in addition to the peaks expected to result from 
the 16S and 12S mitochondrial constituents; the 16S peak may also 
contain IBS cytoplasmic rRNA. RNA from ribosomes prepared from mito­
chondria washed twice with EDTA shows only a minor 28S rRNA component 
(results not shown). When the number of EDTA washes was increased to 
five, 28S RNA was virtually eliminated from the preparation (Figure 8B). 
These data provide clear evidence that washing the mitochondria with 
EDTA prior to treatment with digitonin leads to the removal of the 
major portion of the contaminating cytoplasmic ribosomes while leaving 
the mitochondrial ribosomes functionally active. 
Protein Synthetic Activity of Mitochondrial Ribosomes ^  Vitro 
The requirements for poly(U)-dependent synthesis of polyphenylalanine 
by mitochondrial ribosome preparations are shown in Table 3. Full 
activity required an energy source (ATP and GTP), coli supernatant 
factors (factors from other sources were not examined, however, see 
Discussion), tRNA and ribosomes. Omission of any of these components 
led to a 70-80% reduction in activity. RNA but not DNA was required, 
as evidenced by the results of the assays in which RNase and DNase were 
added. Inclusion of puromycin (1 mM), a potent inhibitor of polypeptide 
synthesis on all known ribosomes (Peska, 1977), led to a 66% reduction 
in polypeptide formation. 
Added messenger RNA was required by the system (Table 3 and Figure 
9). In the absence of poly(U), no nascent polyphenylalanlne was observed 
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Table 3. Requirements for polypeptide synthesis by mitochondrial 
ribosomes in vitro 
Reaction Mix^  CPM [^ H]-polyphenylalanine % 
Complete 76, ,000 (100) 
-Energy 22, 000 29 
-S-100 12, ,000 16 
-tRNA 16, ,000 21 
-Poly (U) 19, ,000 25 
-Ribosomes 22, ,000 29 
Puromycin (1 mM) 26, ,000 34 
DNase (100 pg/mL) 74, ,000 97 
RNase (100 pg/mL) 21, ,000 28 
T^he complete reaction mixture contained, in a final volume of 100 
mL: 10 m Tris-HCl, pH 7.4; 1 mM DTT; 5 mM mercaptoethanol; 0.1 mM GTP; 
1 mM ATP; 4 mM PEP; 11 mM Mg (05^ 000)2; pyruvate kinase, 25 pg/mL; 
30 mM (NH4)2S04; 50 mM KCl; E. coli tRNA, 1 mg/mL; E. coli S-100, 
0.6 mg/mL; poly(U), 0.5 mg/mL; 8 yM [%]-phenylalanine, 54 Ci/mMole; 
cycloheximide, 1 mg/mL and digitonin treated mitochondrial ribosomes. 
After Incubation for 1 hr at 37°C, the samples were prepared for liquid 
scintillation counting as outlined in the Experimental Procedures 
Section. 
Figure 9. Sucrose gradient centrifugation of nascent polypeptides 
synthesized by mitochondrial ribosomes in the presence 
and absence of poly(U) 
Ribosomes from digitonin prepared mitochondria were 
incubated under conditions for polypeptide synthesis with 
(•-•) or without (o-o) poly(U). At the end of 60 minutes, 
the newly synthesized [^ Hj-polyphenylalanine which remained 
associated with the ribosomes was visualized by sucrose 
gradient centrifugation as described in Figure 5. The 
reaction mixture contained 2 mg/mL cycloheximide to inhibit 
cytoplasmic ribosome function. Fractions were prepared 
for liquid scintillation counting as outlined in the 
Experimental Procedures Section. 
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to sediment with mitochondrial rlbosomes on a 10-30% linear sucrose 
gradient (Figure 9). The slight shoulder on the leading edge of the 
mitochondrial ribosome peak was due to contamination by cytoplasmic 
rlbosomes not completely removed by dlgitonin treatment. Experiments 
with poly(C,U) gave similar results; however, despite several attempts, 
3 
we did not observe a poly(C) stimulated incorporation of [ H]-proline 
into trichloroacetic acid Insoluble material. The effect of other 
messengers was not examined. 
Polypeptide synthesis by mitochondrial and cytoplasmic rlbosomes 
had distinctly different magnesium optima. As shown in Figure 10, 
2+ 
optlmura activity with cytoplasmic rlbosomes was obtained at 7 mM Mg 
while mitochondrial rlbosomes had a magnesium optimum at 12 mM. 
Although these results were obtained with poly(C,U), the results were 
similar regardless of the synthetic messenger RNA used. It is clear 
from these results that by assaying for polypeptide synthesis at 
magnesium levels above 10 mM, the contribution from contaminating 
cytoplasmic rlbosomes is minimized. 
The time course for poly(U) and poly(C,U)-directed polypeptide 
synthesis is shown in Figure 11. The reaction was linear for ca. 60 
minutes, after which it reached a plateau. Higher backgrounds (incorpo-
3 
ration without mKNA or rlbosomes) were always observed with [ H]-
3 phenylalanine than with [ Hl-leucine. 
Protein synthesis in this system was dependent on added mitochon­
drial rlbosomes (Table 3); and, within the range of ribosome concen-
Figure 10. Effect of Mg concentration on polypeptide synthesis 
by mitochondrial and cytoplasmic ribosomes 
Mitochondrial (o-o) and cytoplasmic (•-•) ribosomes 
were assayed for poly(C,U)-directed polypeptide synthesis 
in reaction mixtures which contained varying concen­
trations of Mg2+, After incubation the samples were 
processed for liquid scintillation counting as 
described in Experimental Procedures. 
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Figure 11. Time course of polypeptide synthesis by mitochondrial 
rlbosomes 
Ribosomes from dlgitonin treated mitochondria were 
Incubated under conditions for polypeptide synthesis. 
The Incorporation of [%]-phenylalanine into polypeptides 
was examined with (•-•) and without (o-o) poly(U) as 
messenger RNA. The incorporation of [%]-leucine using 
poly(C,U) as messenger RNA was also determined (o-o). 
Aliquots were taken at the times indicated and processed 
for liquid scintillation counting as outlined in the 
Experimental Procedures Section. 
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trations used in these assays (0.1 Aggg to 0.5 Aggg), the response was 
0.1% linear (Figure 12). Assuming = 8 for mitochondrial ribosomes 
(O'Brien and Matthews, 1976), we can calculate that about 210 pmoles 
3 
of [ H]-phenylalanine are being incorporated into polyphenylalanine 
per milligram of ribosomes per hour. 
Effect of Chloramphenicol and Other Antibiotics on In Vitro 
Polypeptide Synthesis by HeLa and 296-1 Mitochondrial Ribosomes 
Because poly(U) was more efficiently translated than poly(C,U), in 
the mitochondrial system, first attempts at showing vitro sensitivity 
to chloramphenicol used the poly(U)-directed polyphenylalanine synthesizing 
system. However, despite repeated attempts with both rat liver and HeLa 
mitochondrial ribosomes, in our hands poly(U)-directed polypeptide 
synthesis was never significantly inhibited by the drug (Table 4). 
Greco jt (1973) and Ibrahim ^  (1974) reported that rat liver 
mitochondrial ribosomes were sensitive to chloramphenicol when assayed 
in a poly(U)-directed polyphenylalanine synthesizing system. The reasons 
for the different responses to chloramphenicol in their experiments and 
ours are not clear. However, a recent report by Ulbrich et al. (1980) 
using rat liver mitochondrial ribosomes, also finds no inhibition by 
chloramphenicol of poly(U)-directed polypeptide synthesis. 
When poly(C,U) was used as a messenger, [ H]-labeled leucine, 
proline and phenylalanine were incorporated into a polypeptide whose 
synthesis on HeLa mitochondrial ribosomes was inhibited by chloram­
phenicol. Table 5 shows the effect of increasing concentrations of 
Figure 12. Effect of mitochondrial ribosome concentration on 
poly(U) directed [%]-polyphenylalanine synthesis 
Varying amounts of ribosomes from digitonin treated 
mitochondria were assayed for their ability to stimulate 
polypeptide synthesis in the standard assay mixture 
(Experimental Procedures Section). After incubation, 
samples were processed for liquid scintillation counting 
as described in the Experimental Procedures Section. 
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Table 4. Effect of chloramphenicol on poly(U)-directed polypeptide 
synthesis by mitochondrial ribosomes from HeLa 
[%] -polyphenylalanine 
Chloramphenicol (pg/mL) CPM^  
0 1.3 X 10^  
100 1.3 X 10^  
200 1.4 X 10^  
400 1.3 X 10^  
A^ssays were conducted as described in Table 3. 
T^he values reported were corrected for incorporation observed in 
an assay without poly(U) (2 X 10^  cpm). 
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Table 5. Effect of chloramphenicol on poly(C,U)-directed polypeptide 
synthesis by mitochondrial ribosomes from HeLa S_ and HeLa 
296-ia 
Chloramphenicol Polypeptide Synthesis (cpm) 
(yg/mL) Ribosomes % 296-1 Ribosomes % 
0 10,300 (100) 21,200 (100) 
5 9,400 (90) 22,900 (107) 
10 8,900 (85) 23,600 (111) 
20 7,400 (72) 26,000 (112) 
50 6,800 (65) 24,100 (113) 
100 6,300 (61) 21,900 (103) 
200 5,700 (54) 21,400 (100) 
400 4,100 (39) 22,200 (104) 
A^ssay was conducted as in Table 3, except that the [^ H]-amino 
acids included were leucine, proline and phenylalanine. 
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chloramphenicol on poly(C,U)-dependent polypeptide synthesis by mito­
chondrial ribosomes from both the sensitive (S^ ) and the resistant 
(296-1) HeLa cell lines. At 400 yg/mL chloramphenicol polypeptide 
production on mitochondrial ribosomes was inhibited by 60%; at the 
same drug level, synthesis on mitochondrial ribosomes from HeLa 296-1 
was unaffected. The level of inhibition by chloramphenicol varied 
somewhat from one experiment to another. In one experiment chloram­
phenicol (400 yg/mL) inhibited HeLa 296-1 mitochondrial ribosome 
function by 45% while mitochondrial ribosomes were inhibited 89%. 
In all cases where mitochondrial ribosomes from both resistant and 
sensitive cell lines were assayed in parallel, HeLa 296-1 mitochondrial 
ribosomes were significantly more resistant to the drug. 
Because the level of inhibition of poly(C,U)-directed polypeptide 
synthesis by chloramphenicol might be influenced by the radioactive 
amino acid used, various combinations of amino acids were tested. With 
all amino acids, HeLa mitochondrial ribosomes were found to be 
sensitive to the drug (Table 6). The greatest Inhibition was observed 
when radioactive leucine or leucine plus proline were used. It is not 
certain why significant Incorporation was observed when only one amino 
acid was added since poly(C,U) is a random copolymer and should code 
for a mixed polypeptide. However, it may be that the level of amino 
acids present in the S-100 preparations used in the reaction was 
sufficient to supply the missing components. The choice of which 
labeled amino acid to use did not appear to be critical for the 
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Table 6. Inhibition by chloramphenicol of the poly(C,U)-directed 
incorporation of various amino acids into polypeptides^  
3 ( H)-amino acid 
100 yg/mL 
Chloramphenicol CPM % of control 
1. (^ H)-leucine 
+ 
8,400 
1,900 22 
2. (^ H)-proline 
+ 
6,400 
2,200 34 
3 3. ( H) -phenylalanine 
+ 
10,300 
2,300 23 
4. (^ H)-leucine 
3 ( H)-proline + 
9,300 
2,700 22 
5. (^ H)-leucine 
3  ^( H)-proline 
+ 
cold serine 
+ 
9,500 
3,700 49 
6. (^ H)-leucine 
3 ( H)-proline 
3 + 
( H)-phenylalanine 
+ 
cold serine 
+ 
13,100 
5,800 54 
7. (^ H)-leucine 
3  ^( H)-proline 
+ 
cold phenylalanine 
+ 
cold serine 
+ 
13,900 
3,600 26 
A^ssay was conducted as described in Table 3, using HeLa S_ mito­
chondrial ribosomes prepared from digitonin treated mitochondria. 
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observation of chloramphenicol sensitivity when poly(C,U) was used as 
mRNA. Therefore, because higher levels of incorporation were observed 
when phenylalanine, leucine, and proline were all labeled, subsequent 
assays were carried out with this mixture of radioactive amino acids. 
Radioactive serine was not included in these experiments because it was 
not commercially available at the high specific activity used in our 
assays, and thus its contribution to observed incorporation would have 
been negligible. 
When present at a concentration of 100 yg/mL, chloramphenicol 
consistently inhibited polypeptide synthesis by HeLa mitochondrial 
ribosomes by about 40%, after one hour of incubation at 37°C. Under 
these conditions, no effect was seen on mitochondrial ribosomes from 
HeLa 296-1. To check for kinetic effects which might be masked by 
taking only a single time point in these assays, the time course of 
poly(C,U)-directed polypeptide synthesis in the presence and absence 
of 100 yg/mL chloramphenicol was determined. Figure 13 shows that 
while the rate of polypeptide synthesis by mitochondrial ribosomes 
from HeLa was inhibited rather uniformly throughout the assay period 
(40% inhibition after one hour at 37°C), the rate of synthesis by 
mitochondrial ribosomes from HeLa 296-1 was unaffected. 
The resistance of ribosomes from HeLa 296-1 mitochondria to chlor­
amphenicol was also evident when the reaction mixtures were analyzed on 
sucrose gradients (Figure 14). As expected, chloramphenicol (100 yg/mL) 
had no effect on the amount of nascent polypeptide associated with mito-
Figure 13. Time course of poly(C,U) directed polypeptide synthesis by 
mitochondrial ribosomes from HeLa Sg and HeLa 296-1 cells in 
the presence and absence of chloramphenicol 
Mitochondrial ribosomes from HeLa S3 (A) and HeLa 29.6-1 (B) 
cells were incubated in a poly(C,U)-directed peptide synthesis 
mixture in the presence (o-o) or absence (#-#) of 100 yg/inL 
chloramphenicol. Aliquots were removed at the times indicated 
and were prepared for liquid scintillation counting as 
described in the Experimental Procedures Section. 
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Figure 14. Sucrose gradient centrifugation of nascent polypeptides 
synthesized by mitochondrial ribosomes from HeLa Sg and 
HeLa 296-1 cells in presence and absence of chloram­
phenicol 
Mitochondrial ribosomes from HeLa Sg(A) and HeLa 296-1 (B) 
cells were incubated in a poly(C,U)-directed polypeptide 
synthesis mixture (containing cycloheximide) in the 
presence (•-•) or absence (o-o) of 100 yg/mL chloram­
phenicol. After incubation, the newly synthesized nascent 
polypeptides were visualized by centrifugation through a 
10 to 30% sucrose gradient as described in Figure 5, The 
gradient fractions were prepared for liquid scintillation 
counting as described in the Experimental Procedures 
Section. 
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chondrlal rlbosomes from HeLa 296-1 (Figure 14B). On the other hand, 
chloramphenicol decreased by 50% the nascent polypeptide associated with 
mitochondrial rlbosomes from HeLa (Figure 14A) . The mitochondrial 
ribosome preparation from HeLa used in this experiment was heavily 
contaminated with cytoplasmic (74S) rlbosomes. As expected, chloram­
phenicol had only a small inhibitory effect (ca. 20%) on the amount of 
nascent polypeptide associated with these cytoplasmic rlbosomes (Figure 
14A). 
There have been several reports in the literature of cases where 
selection for resistance to a drug resulted in selection for cross-
resistance to other drugs as well (Bunn et al., 1970). That is, a 
single mutational event which conferred resistance to one antibiotic 
could sometimes, simultaneously, confer resistance to a seemingly 
unrelated antibiotic. In order to check for this possibility in HeLa 
296-1, resistance to a variety of protein synthesis inhibitors was 
investigated. Table 7 shows the effects of these inhibitors, each at 
a concentration of 2 mM, on poly(C,U)-directed polypeptide synthesis 
by mitochondrial and cytoplasmic rlbosomes. 
Carbomycin and spiramycin, both macrolide antibiotics, and mikamycin 
(streptogramin A), all of which inhibit bacterial peptide bond formation, 
seemed to have little effect on any of the rlbosomes assayed. Linco-
mycin and chloramphenicol, on the other hand, both inhibited polypeptide 
synthesis by mitochondrial rlbosomes from HeLa S^ , while cytoplasmic 
rlbosomes and mitochondrial rlbosomes from HeLa 296-1 were virtually 
unaffected. 
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Table 7. The effect of various antibiotics on poly(C,U)-directed 
polypeptide synthesis on mitochondrial and cytoplasmic 
ribosomes& 
Mitochondrial Ribosomes 
Cytoplasmic Ribosomes HeLa S3 HeLa 296--1 
Antibiotic (2 mM) CPMb % CPM^  % CPM^  % 
None 72,900 100 10,400 100 20,500 100 
Carbomycln 64,800 89 10,300 100 14,700 72 
Spiramycin 76,100 104 9,900 95 23,900 116 
Mlkamycln 46,800 64 11,100 106 15,000 73 
Chloramphenicol 63,900 88 1,800 17 18,800 92 
Lincomycin 61,000 84 4,800 46 17,000 83 
Erythromycin 37,500 51 8,200 79 30,000 146 
Anlsomycln 10,400 14 6,300 69 18,300 89 
A^ssays were conducted as described on Table 3. 
T^he values reported were corrected for incorporation observed in 
an assay mixture lacking ribosomes (16 X 10^  cpm). 
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The effect of erythromycin on this system is quite enigmatic. 
While mitochondrial ribosomes from HeLa seem to be relatively 
unaffected by the drug and cytoplasmic ribosomes are sensitive, mito­
chondrial ribosomes from HeLa 296-1 seem to be stimulated. Erythro­
mycin is known to be an inhibitor of mitochondrial ribosomes vitro 
(Ibrahim ^  , 1974) but not cytoplasmic ribosomes, so an interpre­
tation of this result is not possible at this time and must await 
further investigation. Anisomycin, a potent inhibitor of cytoplasmic 
ribosomes, had little effect on polypeptide synthesis by mitochondrial 
ribosomes. 
Attempts to Prepare Mitochondrial Ribosomal Subunits 
Active in Polypeptide Synthesis 
The results presented thus far clearly show that the mutation to 
chloramphenicol resistance directly affects the susceptibility of mito­
chondrial ribosomes when tested vitro. In order to identify the 
mitochondrial ribosome subunit modified by this mutation, mitochondrial 
ribosomes were dissociated and attempts were made to test their activity 
in vitro. Dissociation was accomplished by dialysis of the mitochondrial 
ribosomes against 1 L of low Mg^  ^KMEDT buffer (1 mM Mg^ )^ overnight 
at 4°C. Because the usual preparation of ribosomes contained large 
amounts of subunits (see Figure 1), 55S monomers isolated from a previous 
sucrose gradient were used. The subunits were separated by centrifuga-
2+ tion on a 10-30% sucrose gradient in low Mg KMEDT buffer for 4 hours 
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at 40,000 rpm in a Beckman type SW 40Ti rotor (Figure 15). After 
dialysis the monomers were completely dissociated into subunits of AOS 
and 3OS (Figure 15). The accumulation of labeled material at the top 
of the gradient suggests that despite purification on a sucrose 
gradient, the preparation still contains nuclease activity. 
When isolated mitochondrial ribosomal subunits were pooled and 
tested for activity, they were found to be completely inactive in poly(U)-
diracted polypeptide synthesis. Subsequent attempts by others in this 
laboratory have produced significantly improved conditions for subunit 
preparation; however, they have not been able to demonstrate poly(U)-
directed polypeptide synthesis with these preparations (D. Hacker, 
personal communication). 
From preliminary experiments (data not shown) it was known that 
2+ 
neither sucrose gradient centrifugation nor incubation in low Mg buffers 
was sufficient to inactivate the mitochondrial rlbosomes. 55S monosomes 
active in poly(U)-directed polypeptide synthesis could be isolated from 
2+ 
sucrose gradients containing 10 mM Mg and rlbosomes preparations 
2+ incubated in 1 mM Mg but not placed on sucrose gradients still 
retained full activity. These results suggested that some factor 
normally present on the ribosome was lost during separation of the sub-
units. 
Denslow and O'Brien (1979) and Ulbrich et al. (1980) had shown that 
elongation factor G, which contaminates mitochondrial ribosomal prepa- • 
tations under normal isolation conditions, is lost when rlbosomes are 
Figure 15. Dissociation of mitochondrial ribosomes by dialysis 
against low magnesium buffer 
HéLa S3 mitochondrial ribosomes labeled ^  vivo with 
[^ Hl-uridine were dialysed overnight (4°C) against low 
magnesium (1 mM) KMEDT buffer. They were then separated 
by centrifugation through a 10 to 30% sucrose gradient 
as described in Figure 5 and 1/lOth volume of each 
fraction was prepared for liquid scintillation counting 
as outlined in the Experimental Procedures Section. 
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washed with high salt-containing buffers and that this factor could not 
be replaced by the analogous coli factor. It could, however, be 
replaced by the homologous factor present in mitochondrial S-100. With 
this in mind, supernatant factors were prepared from the mitochondria of 
rat liver, rabbit liver and HéLa cells (See Experimental Procedures 
Section). None of these preparations stimulated poly(U)-dependent poly­
peptide synthesis by mitochondrial ribosomes or their subunits. In fact, 
each contained a potent inhibitor of poly(U)-directed polypeptide 
synthesis on coli ribosomes (Table 8). 
Several attempts were made to separate the inhibitor from the 
components in S-100 required for protein synthesis. Overnight dialysis 
of rat liver mitochondrial S-100 at 4°C against KMEDT buffer (1 L) 
failed to remove the inhibitor (Table 8). 
When an aliquot of rat liver mitochondrial S-100 was chromatographed 
on Sephadex G-75, two peaks were clearly resolved (Figure 16). The first 
peak (excluded volume) contained mostly protein; the second (included 
volume) contained mostly SNA, as judged by the of the 
fractions. When these fractions were tested, all were found to inhibit 
polypeptide synthesis by coli ribosomes (Table 9). 
Chromotography of rat liver motochondrial S-100 on DEAE cellulose 
separated three peaks (Figure 17). The first peak (mostly protein) was 
eluted with starting buffer (0.02 M phosphate buffer); the second peak 
eluted with 0.25 M phosphate buffer; the third (mostly RNA) eluted with 
0.25 M phosphate buffer containing 1.0 M NaCl. All three fractions con­
tained significant amounts of inhibitory activity (Table 9). 
85 
Table S. Effect of mitochondrial S-100 preparations on poly(U)-
directed polypeptide synthesis with E. coli ribosoraes^  
Mitochondrial 
S-100 added % Control 
None 100 
Rat liver 5 
Rat liver (dialyzed) 7 
Rabbit liver 6 
HeLa 5 
A^ssays were conducted as described in Table 3, except that they 
contained 0.5 A260 of coli ribosomes. Except for the control, each 
mixture contained approximately 30 yg of the indicated mitochondrial 
S-100 in addition to 300 pg of coll S-100. 
Figure 16. Chromatography of mitochondrial S-100 on Sephadex G-75 
One mL of rat liver mitochondrial S-100 (ca. 4mg) was 
applied to an 11 mL Sephadex G-75 column equilibrated 
with KMEDT buffer. The sample was eluted with the 
same buffer. The first mL off the column was discarded 
and 1 mL fractions were collected for the first 4 mL 
after which 2 mL fractions were collected. The 
absorbance at 280 nm (•-•) and at 260 (o-o) was 
determined for each fraction. The width of the bars 
in the figure (o-o) indicates the fraction volume 
collected. 
2.0 
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/tes 
1.0 
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O 0 12 3 4 
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Table 9» Inhibition of poly(U)-directed polypeptide synthesis on 
E^ . coli ribosomes by rat liver mitochondrial S-100 fractions 
separated on Sephadex G-75 and DEAE-cellulose (DE-32)8 
Mitochondrial S-100 fraction^  
Sephadex G-75 CPM % Control 
None 123,600 100 
Fraction 2+3 20,300 16 
Fraction 4 16,200 13 
Fraction 5 23,600 19 
Fraction 6 68,600 " 57 
DEAE-cellulose 
None 81,900 100 
Fraction 6-9 29,800 36 
Fraction 32-38 17,600 22 
Fraction 61-64 53,900 66 
A^ssays were conducted as described in Table 3, except each tube 
contained 0.5 A250 coli ribosomes. After incubation, samples 
were processed for liquid scintillation counting as described in the 
Experimental Procedures Section. 
A^pproximately 15 ug of protein was added. 
Figure 17. Chromatography of mitochondrial S-100 on DEAE-
cellulose (DE-32) 
2 mL of mitochondrial S-100, dialyzed against 0.02 M 
phosphate buffer (pH 7.4), were applied to a DEAE-
cellulose column equilibrated with the same buffer. 
1 mL fractions were collected. Fractions 1 to 27 were 
eluted with starting buffer, fractions 28 to 53 were 
eluted with 0.25 M phosphate (pH 7.4) and fractions 
above 53 were eluted with the same buffer containing 
1 M NaCl. The absorbance at 260 nM was determined 
for each fraction. 
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The inhibitory activity found in mitochondrial S-100 could be due 
to a RNase of lysosomal origin. To test for this possibility, a rat 
liver mitochondrial S-100 was assayed for RNase activity (Table 10). 
Significant RNase activity was detected in the mitochondrial S-100 
preparation, equivalent to 0,5 yg of commercial pancreatic RNase per 
100 yg S-100 protein. 
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Table 10. RNase activity of a mitochondrial S-100 preparation' 
Enzyme source 260 
% of Total ENA in 
supernatant 
None 
RNase (5 lag) 
Rat Liver 
Mitochondrial (100 yg) 
S-100 
0.002 
0.917 
0.093 
0 
9 
0.9 
T^he assay was conducted as described in the Experimental Procedures 
Section. In a final volume of 0.6 mL, 0.1 mL of the solution to be 
assayed was incubated for 30 minutes at 37°C with 62 of the RNA. 
The RNA was then precipitated with an equal volume of IN HCl, 76% ETCH 
and pelleted by centrifugation. A 0.5 mL aliquot of the supernatant was 
diluted to 4 mL with H2O and the absorbance at 260 nm was determined. 
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DISCUSSION 
Isolation and Purification of Mitochondrial 
Ribosomes Active in Polypeptide Synthesis 
Two major impediments to purification of mitochondrial ribosomes 
active in ^  vitro polypeptide synthesis were encountered in these 
studies. They were the persistence of cytoplasmic ribosomes in the 
preparations and the variability of different preparations in their 
competence for polypeptide synthesis. The two problems were related 
in that attempts to separate mitochondrial ribosomes from cytoplasmic 
ribosomes after lysis of the mitochondria, e.g., by sucrose gradient 
centrifugation, resulted in preparations with reduced synthetic activity. 
It was, therefore, necessary to find conditions which allowed the 
preparation of intact mitochondria free of contaminating cytoplasmic 
ribosomes and to use these "clean" mitochondria in the preparation of 
mitochondrial ribosomes. In a first attempt,mitochondria were washed 
with digitonin, a detergent known to remove the outer membrane of 
human liver mitochondria (Benga et , 1979) and, presumably, the 
cytoplasmic ribosomes adhering to it as well. Although this procedure 
significantly reduced the activity of contaminating cytoplasmic ribo­
somes, it failed to eliminate their presence altogether. 
In 1973, Greco et had shown that washing rat liver mitochondria 
with EDTA reduced contamination by cytoplasmic ribosomes. We concluded 
that a combination of the two procedures (digitonin plus EDTA washing) 
might yield mitochondria free of cytoplasmic ribosomes. Although 
Avadhani and Rutman (1974) had successfully used EDTA and digitonin to 
94 
prepare Ehrlich acites cell mitochondrial ribosomes, EDTA washing was 
nonetheless employed with some trepidation. There has been considerable 
controversy over the sedimentation behavior of the Neurospora mito­
chondrial ribosome. Datema et al. (1974) claimed a value of 80S for the 
monomer while Michel et (1977) suggested that the actual sedimentation 
value of the ribosome was 73S. According to Datema e^  , the slower 
sedimenting species resulted from damage incurred by washing the mito­
chondria with EDTA. Because no assay for function was available for the 
Neurospora mitochondrial ribosome, the question could not be resolved 
in a straightforward manner. As we had previously established that we 
could assay HeLa cell mitochondrial ribosomes for poly(U)-directed poly­
peptide synthesis iji vitro, we decided that any significant damage 
incurred by the ribosomes due to washing the mitochondria with EDTA 
prior to lysis, could be detected as a loss of activity in this assay. 
Human mitochondrial ribosomes prepared from EDTA and digitonin 
washed mitochondria were free of contaminating cytoplasmic ribosomes as 
judged by sucrose gradient centrifugation (Figure 6) and by extraction 
and analysis of the ribosomal RNA in polyacrylamide gels (Figure 8). In 
consideration of the somewhat limited sensitivity of these assay tech­
niques, a complete absence of cytoplasmic ribosomes cannot be ensured. 
However, if present, contaminating cytoplasmic ribosomes must represent 
less than 0.1% of the total ribosome population (calculated from the 
relative amounts of each rRNA apecies seen on polyacrylamide gels) 
(Figure 3). The mitochondrial ribosome preparations were active in both 
poly(U) and poly(C,U)-directed polypeptide synthesis when supplemented 
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with tRNA and supernatant factors from coli. Polypeptide synthesis 
by mitochondrial ribosomes had a magnesium optimum distinctly different 
(12 mM) from that of cytoplasmic ribosomes (7 mM) when assayed under 
the same conditions (Figure 10). The mitochondrial ribosomes were also 
resistant to inhibition by drugs known to act on cytoplasmic ribosomes, 
e.g., cycloheximide and anisomycin (Table 7). Taken together these 
findings clearly demonstrate that the procedure described above for the 
purification of mitochondrial ribosomes results in a preparation which 
is essentially free of contaminating cytoplasmic ribosomes, is active 
in polypeptide synthesis vitro when supplied with exogenous factors 
and is therefore, entirely suitable for use in the studies of differential 
antibiotic sensitivity discussed below. 
The Effect of Chloramphenicol and Other Antibiotics on In Vitro 
Polypeptide Synthesis by Hela and 296-1 Mitochondrial Ribosomes 
Poly(U)-directed polypeptide synthesis by coli ribosomes is 
known to be less sensitive to inhibition by chloramphenicol than is 
polypeptide synthesis directed by either natural messengers or other 
synthetic messengers not specifying polyphenylalanine exclusively, 
e.g., poly(C,U) (Pestka, 1977; Vazquez, 1979). The exact molecular 
mechanism of this resistance is not known but it has been suggested 
that either some aspect of the secondary structure of the messenger 
(poly(U)) or the hydrophobicity or aromaticity of the amino acid 
(phenylalanine) allows this aminoacyl-tRNA to compete successfully with 
chloramphenicol for occupation of the A site on the ribosome (Pestka, 
1977). Nonetheless, Ibrahim et al. (1974) and Greco et al. (1973) both 
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reported that chloramphenicol inhibited poly(U)-directed polypeptide 
synthesis by mitochondrial ribosomes vitro. Avadhani and Rutman 
(1974) reported that in an S-25 prepared from Ehrlich acites cell mito­
chondria, synthesis of polyphenylalanine was inhibited by chloramphenicol. 
In more recent reports, Denslow and O'Brien (1978, 1979) compared 
the effect of chloramphenicol on the peptidyltransferase of bovine liver 
3 
mitochondrial ribosomes and ]E. coli ribosomes. When assayed using [ H]-
N-acetyl-leucyl-tRNA and puromycin, twice the concentration of chloram­
phenicol was required for 50% inhibition of mitochondrial ribosomes than 
coli ribosomes. More to the point, Ulbrich et al. (1980), using rat 
liver mitochondrial ribosomes and homologous supernatant factors, 
reported that even at levels 10 times those used by previous investi­
gators (500 yg/mL) chloramphenicol inhibited poly(U)-directed polypeptide 
synthesis by only 15%. In the experiments reported in this thesis, no 
inhibition of poly(U)-directed polypeptide synthesis on human mitochon­
drial ribosomes could be detected even at chloramphenicol concentrations 
of 400 jjg/mL. The reason for the different sensitivities reported by 
these various groups is not clear, but as a result of our inability to 
show inhibition of polyphenylalanine synthesis by chloramphenicol in 
the sensitive (S^ ) cell line, another messenger had to be found. 
Poly(C,U)-directed polypeptide synthesis had previously been shown 
to be as sensitive to inhibition by chloramphenicol as polypeptide 
synthesis directed by natural messenger, when assayed in a system 
containing coli ribosomes (Kucan and Lipmann, 1964; Vazquez, 1966). 
With poly(C,U) as message, chloramphenicol was an effective inhibitor 
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of polypeptide synthesis on HeLa mitochondrial ribosomes as well 
(Table 5). On at least one occasion, however, a level of inhibition 
intermediate between that of the sensitive line and the resistant line 
was seen. It seems clear from these results that the mitochondrial 
ribosome is the component affected by the cytoplasmically inherited 
mutation to chloramphenicol resistance in the HeLa cell line 296-1. 
When the effect of other antibiotics on poly(C,U)-directed poly­
peptide synthesis was assayed using cytoplasmic ribosomes and mitochon­
drial ribosomes from each cell line, several unexpected results were 
obtained. First, polypeptide synthesis was, regardless of the source, 
resistant to carbomycin, spiramycin and mikamycin, drugs known to be 
effective against prokaryotic ribosomes (Table 7). Concentrations of 
these drugs higher than those used (2 mM) may be required to show an 
effect on mitochondrial polypeptide synthesis. It is known that coli 
ribosomes have a 250-fold higher affinity for carbomycin than do bovine 
liver mitochondrial ribosomes (Denslow and O'Brien, 1978). Because of 
the limited solubility of carbomycin, it might be difficult to demon­
strate inhibition of mitochondrial ribosome function by this drug. 
These results are at odds with the report of Ibrahim and Beattie (1974) 
that carbomycin was more effective than chloramphenicol (on a molar 
basis) at inhibiting poly(U)-directed polypeptide synthesis by rat 
liver and yeast mitochondrial ribosomes. Ibrahim and Beattie also found 
that only carbomycin was able to block the binding of [^ C^]-chloram­
phenicol to rat liver mitochondrial ribosomes, erythromycin and linco-
mycin being comparatively ineffective at equimolar concentrations. This 
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suggests that carbomycin has a greater affinity for mitochondrial 
ribosomes than does lincomycin or chloramphenicol. The results reported 
here and those of Denslow and O'Brien suggest that the opposite may 
be true. Whether this difference reflects an authentic species 
difference between the mitochondrial ribosomes of rats, on the one hand 
and cows and humans on the other remains to be seen. 
In a peptidyl transferase assay, Denslow and O'Brien (1978) observed 
that mitochondrial ribosomes were more sensitive to chloramphenicol than 
to lincomycin (on a molar basis). This observation is supported by the 
data presented here. At the same concentration (2 iriM) lincomycin 
inhibited poly(C,U)-directed polypeptide synthesis by 54% whereas chlor­
amphenicol inhibited the reaction by 83%. In contrast, coli ribo­
somes are more sensitive to lincomycin than chloramphenicol (Denslow 
and O'Brien, 1978). 
The observation that mitochondrial ribosomes from HeLa 296-1 are 
relatively unaffected by either chloramphenicol or lincomycin suggests 
that induction of chloramphenicol resistance has led to an alteration 
of the binding site for lincomycin as well. Both drugs are known to 
bind to the large subunit of the bovine liver mitochondrial ribosome 
(Denslow and O'Brien, 1978) and to have overlapping binding sites on 
the E. coli ribosome (Femandez-Munoz et al., 1971; Vazquez, 1966). 
It is not difficult to imagine that a mutation to chloramphenicol 
resistance might lead to a reduced affinity of the ribosome for linco­
mycin as well. It must be noted, however, that this is the first and 
thus far only report of cross resistance between these two drugs. 
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Attempts to Prepare Mitochondrial Ribosomal Subunits 
Active in In Vitro Polypeptide Synthesis 
From the results noted above, it was clear that some macromolecular 
constituent of the mitochondrial ribosome itself had been altered by the 
mutation to a chloramphenicol resistant phenotype. The next logical step 
was identification of the affected subunit. Two different approaches 
were taken in these attempts. The most straight-forward Involved 
dissection of the elongation reaction into its constituent parts. It has 
been established for both coll and bovine liver mitochondrial ribo­
somes that the major binding site for chloramphenicol is on the large 
subunit (Denslow and O'Brien, 1978) where the drug Inhibits the peptidyl-
transferase center of both species of ribosome. 
Despite many attempts, we have never successfully applied the 
peptidyl transferase assay to human mitochondrial ribosomes. The reasons 
for this failure are not clear. It is possible that the ribosome 
preparations were contaminated with lysosomal hydrolases (DeVries and 
Van der Koogh-Schuuring, 1973). These would cause backgrounds too high 
to permit meaningful results. 
The second and more promising approach required separation of the 
ribosomes from both sensitive and resistant strains into subunits and 
then recombinlng the subunits into heterologous ribosomes. Assaying 
these recombinant ribosomes for vitro sensitivity to chloramphenicol 
would then reveal the mutated subunlt. As shown in the Results Section, 
subunits could be separated without difficulty but upon recombinlng, even 
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homologous ribosome preparations were without activity. The most likely 
explanation for this observation is the loss of contaminating elongation 
factors required for polypeptide synthesis on mitochondrial ribosomes. 
Denslow and O'Brien (1979) and, more recently, Ulbrich ^  (1980) 
have reported an absolute requirement for homologous elongation factor G 
by mitochondrial ribosomes. It is possible that during the process of 
isolating subunits, which requires centrifugation in high-salt buffers, 
this factor, normally remaining with the ribosome during preliminary 
purification, is lost or damaged. The recombined subunits, now devoid 
of elongation factor G and unable to use the bacterial analogue, would 
be incompetent for in vitro polypeptide synthesis. It has since been 
found that high salt washed HeLa mitochondrial ribosomes have an absolute 
requirement for mitochondrial S-100 (T. Girard, Iowa State University, 
personal communication). 
Because of the above mentioned considerations, we decided to prepare 
mitochondrial S-100 supernatant factors (see Experimental Procedures 
Section). In every attempt and with mitochondria from all sources tried, 
the S-100 preparations were uniformly contaminated with a high molecular 
weight inhibitor of polypeptide synthesis which co-purified with the 
mitochondria (Table 8). At least one of the preparations was found to 
contain RNase activity. As dlgitonin had been used to pfeferentlally 
eliminate contaminating lysosomes from the mitochondrial preparations 
(Loewenstein ^  , 1970), hydrolases should havg been a minimal problem. 
It has been noted that the method chosen to evaluate mitochondrial 
protein (O.D. at A550) gave varying results depending on the exact buffer 
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composition and method used to resuspend the mitochondria. This could 
have caused the digitonin treatment to be less effective than it might 
have been (J. Horowitz, Iowa State University, personal communication). 
Recent findings suggest that the mutation is not likely to have 
affected a ribosomal protein. The only ribosomal proteins known to be 
encoded in mitochondrial DNA are found on the small subunit (Lambowitz 
et al., 1979; Terpstra et al., 1979) which is not believed to be the 
major binding site for chloramphenicol (see Introduction). Additionally, 
Dujon (1980) has reported that the large subunit mitochondrial rRNAs from 
two different chloramphenicol resistant strains of yeast each contain a 
single base change from wild type. In more recent reports, Kearsey and 
Craig (1981) and Blanc ^  (1981) have shown that similar single base 
changes also occur in the large subunit mitochondrial rRNAs from 
chloramphenicol resistant mouse (3T3 and LA9) and human (HeLa B) cell 
lines. They note that all 5 point mutations occur in one or the other 
of two distinctive sequences (10 and 13 bases long) which occur toward 
the 3' end of these molecules. In wild type cells from yeast, mouse and 
human these sequences are completely conserved. The 23S rRNA of JE. coli 
also contains a region in which these sequences occur (Brosius jet , 
1980) suggesting they may play some fundamental role in protein synthesis, 
perhaps involving peptidyl transferase center (Blanc ^  , 1981). 
It has been noted (C. D. Wallace, Stanford University, personal 
communication) that a similar base change occurs in the 165 mitochondrial 
ribosomal RNA of HeLa 296-1. This observation combined with the data 
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presented in this thesis provide strong evidence that the chloramphenicol 
resistant phenotype of HeLa 296-1 is the direct result of a single base 
change in large subunit rRNA of the mitochondrial ribosome. 
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